Gold catalyzed heterocyclization processes. by Manzo, Angelo Maria
UNIVERSITA’ DEGLI STUDI DELL’INSUBRIA 
 
SEDE DI COMO 
 
Facolta’ di Scienze MM.FF.NN. 
 


















PhD Supervisors: Prof. Gianluigi BROGGINI 
 




Doctoral candidate:  
 



















1. Introduction .....................................................................................................................1 
1.1 Gold catalyzed nucleophilic addition to C-C multiple bonds ..........................................2 
1.2 Gold catalyzed hydroamination of C-C multiple bonds...............................................3 
1.3 Gold catalyzed hydroalkoxylation of C-C multiple bonds............................................7 
1.4 Gold catalyzed functionalization of Csp
3-H, Csp
2-H, Csp-H bonds..................................11 
 
2. Results and Discussion...........................................................................................15 
2.1 Gold catalyzed intramolecular hydroamination of α-aminoallenamides .......................15 
2.2 Synthesis of propargylamides 3a-f............................................................................16 
2.3 Synthesis of α-aminoallenamides 4a-f ......................................................................17 
2.4 Optimization of cyclization conditions on α-aminoallenamide 4a with gold catalysts 17 
2.5 Synthesis of 5-substituted 2-vinylimidazolidi-4-ones 5a-f ............................................19 
2.6 Synthesis of α-benzylamino allenamide 13...............................................................22 
2.7 Gold catalyzed intramolecular Csp
2-H alkylation ...........................................................25 
2.8 Synthesis of 1-H-pyrrole-2-carboxamides 16a-b......................................................26 
2.9 Gold catalyzed cyclization of 1-H-pyrrole-2-carboxamides 16a-b................................26 
2.10 Solvent effect in determining the ratio between products 17b and 18b in AuCl3 catalyzed 
cyclization ..................................................................................................................28 
2.11 Synthesis of propargylamides 19 and 20a-d...........................................................29 
2.12 Gold catalyzed cyclizations of N-substituted-carboxamides 20a-d.............................32 
2.13 Synthesis of propargylamides 20e-g.......................................................................34 
2.14 Gold catalyzed cyclizations of N-substituted-carboxamides 20e-g.............................35 
2.15 Hypothesis of reaction mechanism for the formation of substrates 20a-d and 20e-g..36 
2.16 Gold catalyzed intramolecular hydroalkoxylation of C-C triple bonds .......................40 
 
 
2.17 Synthesis of 2-(prop-2-yn-1-ylamino)phenol 31a...................................................42 
2.18 Optimization of gold catalyzed cyclization conditions on 2-(prop-2-yn-1-ylamino)phenol 
31a..............................................................................................................................42 
2.19 Synthesis of 8-hydroxyquinoline 35a......................................................................44 
2.20 Synthesis of 2,3-dihydro-2-methylene-1,4-benzoxa ine 32a.......................................45 
2.21 Synthesis of 2-substituted (prop-2-yn-1-ylamino)phenols 31b-d................................46 
2.22 Synthesis of 2-substituted (prop-2-yn-1-ylamino)phenols 31e-g.................................47 
2.23 Synthesis of 2,3-dihydro-2-methylene-1,4-benzoxa ines 31b-f by gold catalysis ......49 
2.24 Synthesis of 2-(prop-2-yn-1-yloxy)phenol 41 and 3-(prop-2-yn-1-yloxy)naphtalen-2-ol 
42................................................................................................................................51 
2.25 Synthesis of 2-methylidene-2,3-dihydro-1,4-benzodioxines 43 and 44 by gold catalysis 
....................................................................................................................................52 
2.26 Hypothesis of reaction mechanism for the formation of 1,4-benzoxazines 32a-g and 1,4-






























Gold is probably the sole chemical element that literally every person has heard about. Its highly 
positive potential is responsible for a low reactivity and diffusion in nature in elemental form. One 
of the most important characteristics of gold is its durability. In fact a lot of ancient art is made of 
gold. In the past, the monetary system was based on rare gold and as a result this metal was also 
responsible for gold rushes, wars, conquering of whole continents. 
Gold is also used in medicine, such as, in dental he t care, in arthritis treatments, and recently its 
anticancer activity has been discovered. Metallic gold is highly biocompatible but gold in ionic 
form is toxic.1 
 Organic chemists didn’t use gold as a catalyst in the past probably because of the low reactivity 
deduced from the inertness of the elemental gold that only dissolves in aqua regia or oxidants such 
air in presence of strong ligands. 
Another reason that prevented the use of gold as potential catalyst, was the high value associated 
with this metal and the idea that such a catalyst would be unaffordable. This idea is changing for 
many reasons: monetary systems are not based on gold, the so called “queen of metals” is now less 
expensive than other metals like rhodium, palladium and platinum. Thousand tons of gold are 
recycled from stoichiometric technical applications and the same amounts is produced in gold 
mines every year. This is an advantage compared to rhodium, palladium and platinum because 
determines a high stability of its price and can justify its use for industrial applications. 
Gold catalysts, because of their unique properties have now become well-established best option for 
many chemical transformations in both heterogeneous and homogeneous processes. Gold salts can 
promote chemical transformations at room temperature with reaction times of just minutes.2 This 
contrasts with other metal-catalyzed reactions that require higher temperatures and reaction times of 
hours or even days. Furthmore the high reactivity of many metal complexes renders the reactions 
they catalyze sensitive to both air and moisture and limits their practical utility. Conversely, gold 
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derivatives are robust transition metal catalysts showing air and moisture tolerance and generation 
only of environmentally safe byproducts.3 Moreover Au(I) has a good redox stability under ambient 
conditions and this allows the development of a new way of reactivity without the traditional 
oxidative addition/reductive elimination cycles so present in late transition-metal catalysts. 
Gold catalysts can work very often without ligands under mild conditions and are effective even 
when very small amounts are used.4 
 
1.1 Gold catalyzed nucleophilic additions to C-C multiple bonds 
C-C multiple bonds of alkynes, allenes, or olefins coordinate to gold complexes; in this way gold 
efficiently activates them for the attack of a nucleophile. Other metals like Hg2+ are able to activate 
C-C multiple bonds of alkynes or olefins but the resulting C(sp3)-Hg bond is usually kinetically 
stable and requires an extra step to release organic ligand. Thus the overall transformation become 
stoichiometric in toxic mercury salts.5,7 Gold catalysis is able to solve this problem because the C-




As depicted in Scheme 1, gold catalyst coordinates th  π-system of the substrate to form an 
organogold intermediate that undergoes nucleophilic attack. There’s evidence that the nucleophile 

















attacks anti to gold to deliver the vinylgold intermediate.8 Then the organogold intermediate 
liberates the addition product and the gold catalys b  protodemetallation. 
 
 
1.2 Gold-catalyzed hydroamination of C-C multiple bonds 
Nitrogen-containing heterocycles are a broad and important class of compounds widely spread in 
nature,9 often with very high biological activity.10 Limitations associated to traditional methods for 
C-N bond formation prompted organic chemists to investigate catalytic addition of N-H bond across 
a C-C multiple bond as an atom-economical and straightforward route to the synthesis of amine 
derivatives. 
As depicted in Scheme 2, a potential catalytic cycle for hydroamination has been hyphotesized. The 
C-C multiple bond is activated toward nucleophilic attack by complexation to an electron-deficient, 
late-transition-metal complex.11 The following protonolysis releases the amine derivative and 
regenerates the catalyst. 
This approach to hydroamination is suitable for late-transition-metal complexes because they have 
low oxophilicity and display good tolerance to many functional groups but low air and moisture 
sensitivity as well. However amines have a very high l ating ability and so they can often poison 
the metal forming stable complexes without delivering the desired product. Moreover the metal-
alkyl complexes formed by nucleophilic attack are often resistant to protonolysis and can give β-



















              
AuIII  and cationic AuI are very carbophilic Lewis acids and are able to ac iv te C-C multiple bonds 
toward nucleophilic attack.14 These complexes, AuI in particular, being so little oxophilic, display 
very good functional group compatibility and low sen itivity to air and moisture. Moreover 
alkylgold complexes are stable to β-hydrogen elimination and are highly reactive with respect to 
protonolysis of the Au-C bond.15,16 These are the reasons why AuIII  and AuI are widely used in 
hydroamination reactions of alkynes, alkenes, allenes. 
Many examples of gold catalyzed inter and intramolecular hydroamination reactions are present in 
literature. In particular, gold catalyzed intramolecular cyclization is very interesting. The first 
example of AuIII-catalyzed intramolecular hydroamination to form tetrahydropyridine was reported 





































AuIII  catalyzed hydroamination of 2-(1-alkynyl)-anilines to form 2-(butyl)-indole was also reported 

















One of the most difficult and challenging goal in homogeneous catalysis is the hydroamination of 
inactivated alkenes. AuI catalyzed intramolecular hydroamination of unactivated alkenes with 



































Intramolecular cyclization of allenes with tethered amines, in the presence of a transition metal 
catalyst represents the most common route to generat  nitrogen-containing heterocycles. Allenes are 
more reactive towards transition metals than alkenes and AuI as well as Au III  are able to catalyze at 















Effective protocols for the xo-hydroamination of N-allenylcarbamates catalyzed by 









































1.3 Gold catalyzed hydroalkoxylation of C-C multiple bonds 
 
 
Water and alcohol can serve as nucleophiles in inter and intramolecular gold catalyzed 
hydroalkoxylation reactions of alkynes. These reactions were known to be catalyzed by mercury (II) 
salts under very acid conditions or by palladium or platinum (II) salts.22 
The first catalytic alkynes hydration with gold catalyst (HAuCl4) appeared in 1976.
23 Then Utimoto 
et al. discovered that with 2% mol of Na[AuCl4] as catalyst, water and alcohols can be used as 
















































y = 28-94% y = 85-95%
8 
 
Intramolecular addition of a hydroxyl group to a C-C triple bond was also reported. Catalytic 
amounts of AuCl and K2CO3 are able to convert ω-acetylenic alcohols in α-alkylidene oxygenated 

















(Z)-3-Ethynylallylalcohols can be transformed to furans using both gold(III) and gold(I) in different 










































R1-R5 = alkyl,aryl,H (for R5 not H : 83-97%) (for R5 = H : 12-100%)
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Also simple olefins can be activated by gold toward the inter and intramolecular  hydroalkoxylation 
reactions. An example is the formation of phenyl-alkyl ethers using gold(I) as a catalyst.28 Cationic 
gold(I) binds and activates olefins allowing the nucleophilic attack of phenols or carboxylic acid 











                                                                                                                        
 
 
The first intramolecular addition of a hydroxyl group to an activated alkene using gold catalysis was 







































Allenes are not simple substrates because they showproblems linked to the chemo, regio and stereo 
selectivity.30 The intramolecular hydroalkoxylation of allenes was reported by Krause and 
Hoffmann-Röder for the cycloisomerisation of allenyl carbinols to give 2,5-dihydrofurans with 












Both gold(I) and gold(III) are able to cyclomerize β-hydroxyallenes leading to dihydropyrans in 
















































1Au (I) or Au (III)
DCM, rt
R1, R2, R3 = H, alkyl
R4 = CO2Et, OAc
R5,R6 = H, Me
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1.4 Gold catalyzed functionalization of Csp3-H, Csp2-H, Csp-H bonds. 
The activation and functionalization of C-H by metal complexes is a very difficult problem in 
organic chemistry but the importance for this organic transformation encouraged chemists to try 
new metal catalysts to achieve better results.33 
Gold(I) and gold(III) are both able to activate and functionalize C-H bonds. An example of Csp
3-H 
bond functionalization is the intramolecular alkylation of 1,3-dicarbonyl compounds that is 
achieved using AuCl3/AgOTf as a catalytic system.
34 In this field an attractive target is the synthesis 
of substituted lactams by intramolecular addition of β-ketoamide to unactivated alkenes using 

















































Very interesting is the activation and functionalizt on of a Csp
2-H bond. The first report of 
hydroarylation of alkynes by gold was reported by Reetz and Sommer.36 Hydroarylation mechanism 
is not well defined. Two different hypothesis have been considered: the first is a Friedel-Craft like-
mechanism involving activation of the alkynes by carbophilic gold center (Scheme 15 A).36 The 
second one involved the formation of an aureate arene gold intermediate that attacks the activated 



















Electron rich arene like pyrrole, indoles, furans, etc. can react, as the nucleophiles, intramolecularly 
with alkynes, alkenes or allenes in the presence of a gold catalyst to give from six to eight 
membered ring annulated compounds (Scheme 16).38,39 
 
 














































A further example of Csp
2-H bond functionalization is the synthesis of phenols starting from ω-
alkynyl furans using AuCl3 as a catalyst reported by Hashmi’s group. The reaction showed high 


























20 % mol AgOTf
y = 54-75%









Gold is also able to functionalize Csp-H bond, for example the activation of C-H of 1-alkynes in the 
Sonogashira coupling with aryl iodide can be accomplished using gold(I) complexes instead of CuI 
as a cocatalyst.41 The reactions are cleaner and can be carried out in technical grade solvent without 
















The C-H bond activation of 1-alkynes by gold has been used by Wei and Li as well as in the three 


























   53-99%
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2. Results and Discussion 
2.1 Gold catalyzed intramolecular hydroamination of α-aminoallenamides 
Intramolecular hydroamination, the formal addition f N-H group to carbon carbon multiple bond, 
is a direct and efficient procedure for the synthesis of nitrogen-containing heterocycles.43 
Cyclization of allenes with tethered amines represents a fruitful route for this scope. Some 
alternative strategies based on basic44 or transition metal-catalysts45 have been used for this purpose. 
Among the latter palladium,46gold,47silver,48ruthenium,49copper,50cobalt,51 mercury,52, and 
titanium,53 warrant a wide range of procedures such as domino reactions, oxidative cyclizations, 
cyclocarbonylations, and cycloisomerizations which allow them to differently achieve functional 
products. 
In recent years homogeneous catalysis using gold salts h s emerged in organic synthesis as a 
powerful arm for interesting and useful transformations.54 The success of the gold catalysis 
involving allene substrates is related to its ability to coordinate with C-C bonds, thereby allowing 
the attack of various nucleophiles both  in inter- and intramolecular fashion.55 
Taking into consideration recent works on heterocyclization of α-amino allenamides A, under base-
promoted56 and domino palladium-catalyzed57 conditions to give dihydropyrazinone and 
imidazolidinone B and C, respectively (Scheme 20), we thought of undergoing these substrates 


































This study was carried out with the double aim i) to perform an alternative procedure to enter to 
optically active nitrogen-containing heterocycles, and ii) to investigate the feasibility of gold 
catalyzed heterocyclization of  compounds having amine and allene groups tethered on an amido 
group. 
In the following chapters the results of our research group, concerning gold-catalyzed 
intramolecular hydroamination of allenamides A leading to enantiopure 5-substitued 2-
vinylimidazolidinone, are reported. The imidazolidinone derivatives are widespread in several 
natural products, many of them having biological activities.58 Moreover, imidazolidinones have 
proved to be effective in organic catalysis as activ tors for α,β-unsatured aldehydes through 
formation of an iminium ion.59 
 
2.2 Synthesis of propargylamides 3a-f 
Propargylamides 3a-f were obtained in good yields (Table 1) by the reaction of L-α-aminoacids 1a-
f and N-methylpropargylamine 2a in DCM as a solvent at rt and using DCC as an amido-formation 
coupling reagents (Scheme 21). 
  
                                                  Scheme 21                                                   Table 1  
 
 


































a: R = i-Pr; b: R = Me; c: R = Bn; d: R = tert-Bu; e: R = Et; f = Ph
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2.3 Synthesis of α-aminoallenamides 4a-f 
 
Propargylamides 3a-f were transformed into α-aminoallenamides 4a-f by t-BuOK promoted 
isomerization in dry THF (Scheme 22). The exposure tim  of 3a-f to the base is crucial and must 
not exceed 1 minute, so as to prevent the base-promoted cyclization reaction.56 Yield of products 
reaction are often near quantitative (Table 2). 
 
 


















2.4 Optimization of cyclization conditions on α-aminoallenamide 4a with gold catalysts. 
 
The allenamide 4a, arising from L-valine, was used as the first model-substrate to test the 
cyclization reaction to give the corresponding 5-isopropyl-2-vinylimidazolidinone 5a by gold 
catalysis (Scheme 23). Reaction conditions were optimized by using a variety of Au(I) and Au(III) 














































Table 3. Optimization of the cyclzation conditions of 4a 
 
Entry Catalytic systema Solvent Reaction products (%)b 
   1a 5a 6 7 8 
1 H2SO4c MeCN - 15 85 - - 
2 AuCl toluene 95 - - 5 - 
3 AuCl MeCN 93 - - 7 - 
4 PPh3AuCl, AgOTf CH2Cl2 90 - - 10 - 
5 PPh3AuCl, AgOTf, AcOH CH2Cl2 92 - - 8 - 
6 AuCl3 MeCN - 90d - 10 - 
7 AuCl3 dioxanee 80 10 - 10  
8 AuCl3 AcOHf - - - 10 90 
9 AuCl3 CH2Cl2g 95 - - 5 - 
10 AuCl3, AgBF4 toluene 95 - - 5 - 
11 NaAuCl4·2H2O MeCN 51 39 - 10 - 
12 NaAuCl4·2H2O CH2Cl2g 95 - - 5 - 
13 NaAuCl4·2H2O dioxane 95 - - 5 - 
14 AuCl3, AgOTf MeCN 90 - - 10 - 
15 AuCl3, AgOTf AcOHf - - - 10 90 
a Au-catalyst is used in 5 mol% 
b Ratio determined by HPLC  
c 5 mol% 
d As a 2.5:1 cis/trans diastereoisomeric mixture 
e Working on DMF, MeOH and toluene any conversion of 5a was observed 
f At 70 °C 




First of all, in order to determine the need of a gold species for obtaining the cyclization process, a 
control investigation was performed submitting the compound 4a to reaction catalyzed by protic 
acid. This procedure provided the formation of 5a in 15% yield beside a large amount of 
deallenylation by-product 6 (Figure 1) making of no value its applicative interest (entry 1). It should 
be outlined that Yb(OTf)3 revealed a catalytic behaviour similar to the sulph ric acid while other 
Lewis acids such as BF3.Et2O and Zn(OTf)2 afforded only a tarry mixture. 
Treatment of α-amino allenamide 4a with Au(I)-salts only resulted in the formation ofsmall 
amounts of the degradation product 7 (entries 2-3). The same behaviour was observed by using 


















Working in the presence of AuCl3 (5 mol%) in acetonitrile as solvent at reflux, a mixture of 
imidazolidinones 5a was obtained in satisfactory yield (entry 6). Other solvents as dioxane, DMF, 
MeOH and toluene were tried without improving the cyclization outcome. By performing the 
reaction in AcOH as solvent at 70°C, only the open chain derivative 8 (Figure 1) was recovered 




2.5 Synthesis of 5-substitued 2-vinylimidazolidinones 5a-f 
Having optimized the reaction conditions for the cyclization of allenamide 4a on a small scale 
(Table 3, entry 6), we tried to scale-up the reaction in order to isolate reaction products. AuCl3 (5 
mol%) was added to a solution of 4a in acetonitrile dry. The mixture was refluxed for 2 h then 
solvent was evaporated to dryness. The crude was purified by flash column chromatography 









































The absolute stereochemistry of the cis and trans diastereoisomers 5a was assigned by NOE 
measurements. In particular, NOE enhancement between Hb and Ha has been determinant to 
identify the cis-configuration of the major diastereoisomer. The trans-configuration of the minor 


































































HPLC analysis (Chiracel ODH column) of cis- and trans-5a, performed in comparison to samples 
of the corresponding racemic mixture synthesized starting from the (±)-valine, proved an 
enantiomeric purity better than 99.5%. 
Next we explored the scope of the reaction under the conditions of entry 6 Table 3. Thus a selection 
of the behaviour of allenamides 4 is collected in Table 5. 
 










Entry Allene R Time (h) Yields of products (%) 





























trans-5b (12%)  












trans-5c (12%)  












trans-5d (4%)  












































The reactions were completed in 1-3.5 h, always providing the cis-imidazolidinone as major 
product. Allenamides 4a-f led to cis and trans products in very similar ratios and yields. The 
outcome of compound 4e resulted in a crude tarry mixture that allowed isolating cis 
disterereoisomer in only 22% yield. 
Allenamide 4f, arising from L-phenylalanine, gave rise to cyclization in a higher diastereoselective 
level that led to the isolation of the sole cis-product in 65% yield. 
 
2.6 Synthesis of α-benzylamino allenamide 13 
The inertness of Au(I)-catalysts prompted us to study the behaviour of a substrate having a more 
nucleophilic amino group.  
The α-amino allenamide 13 was synthesized for this purpose in four steps. 
Starting from the corresponding Fmoc-L-valine 9, the corresponding propargylamide 10 was 
synthesized using the usual protocol for the synthesis of propargylamides 3a-f. The Fmoc protecting 
group was then removed using piperidine in acetonitrile as solvent at room temperature in 6 h. The 











The intermediate 11 was then alkylated on the free nitrogen using benzylbromide leading to the 






















into the corresponding α-benzylaminoallenamide 13 by the same procedure used to obtain 










The α-benzylaminoallenamides 13 underwent to treatment with Au(I) and Au (III) catalysts. 
Although even in this case the latter turned out to be the most efficient catalyst, PPh3AuCl was 
operative in the promotion of the 5-exo-allylic cyclization (Table 5). 
 


















The reaction which was carried out in the presence of AuCl3 was faster than cyclization tried on 
allenamide 4a (0.20 h vs 2.5 h) giving the cis isomer as the major product, although with a lower 
Entry Catalytic system Time (h) Yields of products (%) 
1 PPh3AuCl/AgBF4 2.5 cis-14 (21%) trans-14 (14%) 
















































cis/trans ratio. The catalytic system PPh3AuCl/AgBF4 furnished the cis and trans imidazolidinones 
14 with the same diasteroisomeric ratio found using AuCl3 as catalyst although in lower yield. 
 
A plausible mechanism for the gold-catalyzed heterocyclization is shown in Scheme 27. The inside 
C-C double bond of the 1,2-diene moiety is activated by the coordination of both Au(I) and Au(III) 
species (intermediates A or A’ ), the so generated π-olefin complex undergoes intramolecular 
nucleophilic attack by the nitrogen atom of the amino group affording the cyclic vinyl-gold 
intermediate B. However, the development of the C-N bond can be achieved on the π-olefin-Au(III) 
complex by both Boc and Bn-amino groups, whereas only the more reactive Bn-amino group can 
interact with π-olefin-Au(I) complex. Protonolysis of the gold-carbon bond B gives 

























































2.7 Gold catalyzed intramolecular Csp
2-H alkylation 
 
Our following work has been addressed towards studies on cyclization of alkynyl-substituted 
heterocycles.60 Homogeneous gold catalysis, has emerged recently as a powerful tool to achieve 
such a goal, mainly to the chemoselective alkynophilic properties of this attractive metal.61 
As already mentioned in the introduction, the first example of an intermolecular hydroarylation of 
alkynes has been reported independently by Reetz36 and Shi,37 whilst the development of the first 
intramolecular version of this reactivity dates back to 2004.62 From then on, several different 
reacting partners have been successfully tested under various conditions, developing a large family 
of gold-catalyzed carbo- and heterocycle synthesis.63 
However, electron-rich aromatic heterocycles have be n under-investigated in comparison to arylic 
substrates. To the best of our knowledge, only two papers dealing with hydroarylation of indoles 
have been published,64 and just one reports the effectiveness of their coupling with internal 
alkynes.64b 
The research group I have worked for, elaborated some protocols65 to obtain complex 
(poly)heterocyclic system by intramolecular palladium-catalyzed reactions. In particular they 
reported the cyclization of N-allylpyrrolo-2-carboxamides which exhibited also products arising 









































So we were intrigued to investigate the intramolecular hydroarylation of alkynyl pyrrolo-2-
carboxamides catalyzed by gold in order to i) study the feasibility of gold-catalyzed intramolecular 
hydroarylation of alkynes tethered via an amido group onto pyrrole skeleton, ii) obtain an 
alternative procedure to access pyrrole fused heterocycles, and iii) verify an analogous outcome in 
terms of rearrangement behaviour. 
 
2.8 Synthesis of 1H-pyrrole-2-carboxamides 16a,b 
1H-Pyrrole-2-carboxamides 16a,b were synthesized from the corresponding 1H-pyrrole-2-











15a: R1= H 16a ( 80%) 








2.9 Gold catalyzed cyclization of 1H-pyrrole-2-carboxamides 16a,b 
 
The two 1H-pyrrole-2-carboxamides 16a,b were submitted to gold catalyzed cyclization reactions 








































At first, it should be noticed that both Au(III) and Au(I) catalysts were unable to cyclize the 
nitrogen unsubstituted pyrrolo derivative 16a (entries 1-5). This behaviour was completely different 
from what was observed in Pd-catalyzed reactions, where N-allyl pyrrole-2-carboxamides did not 
require this substitution to react. Otherwise AuCl3 was able to promote the cyclization of the 
substrate 16b, bearing a methyl group on the pyrrolic nitrogen, giving two isomeric bicyclic 
products. Their structures were unequivocally determined to be the expected 6-exo-dig cyclization 
product 17b and the cyclized rearranged structure 18b by 1H NMR, 13C NMR, NOESY1D, gHSQC 
and 1H-13C long-range correlations (gHMBC) experiments (Figure 3). 
 
 
Entry Substrate Gold catalyst[a] Solvent[b] 17[c] 18[c] 
1 16a AuCl3 MeCN - - 
2 16a NaAuCl42H2O MeCN - - 
3 16a AuCl DCM - - 
4 16a PPh3AuCl/AgBF4 DCM - - 
5 16a AuCl3 DCM - - 
6 16b AuCl3 MeCN 63 37 
7 16b NaAuCl4.2H2O[d] MeCN 30 17 
8 16b AuCl DCM - - 
9 16b PPh3AuCl/AgBF4 DCM - - 
[a] Catalyst loading: 5 mol %. [b] All reactions were carried out at reflux for 4 h. [c] HPLC conversion. [d] In this 





















16a: R = H





















The best result was obtained when the reaction was performed in MeCN at reflux for 4h (entry 6); 
in this case, the ratio between 17b and 18b, determined by HPLC, was 63:17. 
NaAuCl4.2H2O was also able to cyclize 16b, but in this case, after 4h in MeCN at reflux, the 
conversion of the substrate resulted in only 50%, givin  a mixture of 17b and 18b that the HPLC 
analysis revealed to be in 30:17 ratio (entry 7). Despite the nitrogen substitution, Au(I) didn’t afford 
any cyclization product of the substrate 16b (entries 8-9). 
 
 
2.10 Solvent effect in determining the ratio between compounds 17b and 18b in AuCl3 
catalyzed cyclization. 
We observed that the catalytic effect of AuCl3 in determining the cyclization of the amide 16b was 
influenced by the reaction medium. In particular, the ratio between the cyclization products 17b and 












































In fact, operating in non polar solvents increased the formation of 17b (entries 1 and 2), whilst 
changing to polar solvents, an enhanced products ratio until a majority of 18b was obtained (entry 
4). More specifically, the ratio (HPLC-MS) between 17b and 18b changed from 7:1 working in 
toluene to 1:1.6 when DMF was used. This means that less polar solvents favour the expected 
cyclization product 17b whereas more the polar ones favour the formation of compound 18b, 
arising from the formal 1,2-migration of the amide moiety. 
 
2.11 Synthesis of  propargylamides 19 and 20a-d 
Other propargylamides were synthesized. Some of these r quired the previous synthesis of 








    
  
Entry [Au][a] Solvent T (°C) t (h) Ratio[b]  17b[c] 18b[c] 
1 AuCl3 Toluene 50 3 7:1 70 8 
2 AuCl3 DCM reflux 3 3:1 41 16 
3 AuCl3 MeCN reflux 4 1.7:1 45 26 
4 AuCl3 DMF 90 4 1:1.6 32 50 













15b  19 (80%)2b
30 
 
The propargylamide 20a was prepared in good yield adopting the same procedure used for 











    
 
 
Propargylamide 20b was obtained starting from 15b and using 4-methyl-N-(prop-2-yn-1-
yl)benzenesulfonamide 2d as coupling partner. In this case because of the low nucleophilicity of the 
amide 2d, the formation of 20a required the synthesis of the corresponding acylchloride from 15b 




















































Then we prepared propargylamides 20c and 20d, starting from the intermediate 19. For 20c, Boc 
anhydride was added to a solution of 19 in MeCN using a catalytic amount of DMAP. For 20d, 
deprotonation of the amidic proton of 19 with NaH was necessary for the efficient acylation with 

































































2.12 Gold catalyzed cyclizations of N-substituted-carboxamides 20a-d 
 
Propargylamides 20a-d were submitted to the gold-catalyzed cyclization in order to confirm the 
trend of the observed dependence of the direct and rearranged cyclization products on different 
solvents already observed for propargylamide 16b. 
The results obtained are summarized in Table 8 where the isolated yields as well as the HPLC-MS 
areas isomeric ratios are depicted. 
 






Entry[a] Substrate R Solvent T(°C) t(h) Yield (%) [b] HPLC-MS ratio[c] 
      21 22 23 24 25 26  
1 20a Bn Toluene 45 0.5 84 7 - - - - 7.5 : 1 
2 20a Bn DCM reflux 0.25 61 12 - - - - 3 : 1 
3 20a Bn MeCN reflux 0.25 50 25 - - - - 1.6 : 1 
4 20b Ts TBME RT 1.5 85 7.5 - - - - 9 : 1[d] 
5 20b Ts DCM reflux 0.5 75 9 - - - - 6 : 1[d] 
6 20b Ts Toluene 45 0.5 65 14 - - - - 4 : 1[d] 
7 20b Ts MeCN reflux 0.5 70 20 - - - - 3 : 1[d] 
8 20b Ts DMF 90 7 60 25 - - - - 2 : 1 
9 20c Boc Toluene 50 1 - - 56 14 - - 2.5 : 1 
10 20c Boc DCM reflux 1 - - 20 30 - 5 1 : 1.5 : 0.2 
11 20c Boc MeCN reflux 3 - - - - - 65[d] 1 
12 20d Bz Toluene 50 1 51 - 9 - 6 - 30 : 2.3 : 1 
13 20d Bz DCM reflux 1.5 60 10 - - - - 7 : 1 
14 20d Bz MeCN reflux 1 50 13 - - - - 5 : 1 
15 20d Bz DMF 90 24 3 - - - 40 11 1 : 10[e] : 5 
[a] All reactions were carried out using 5 mol % AuCl3. [b] Isolated yield. [c] HPLC-MS ratio between peak areas. [d] After cromatographic column 33% of  




































+ + + + +
conditions
(see Table 10)
20a-d 21a-d 22a-d 23a-d 24a-d 25a-d 26a-d
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Substrates 20a and 20b underwent AuCl3 catalyzed cyclization in all solvents at different reaction 
temperatures affording respectively the pyrrolo-pyridines 21a (entries 1-3) and 21b (entries 4-8) 
and the rearranged bicyclic derivatives 22a (entries 1-3) and 22b (entries 4-8).  
Conversely, substrate 20c, having a t-butoxycarbonyl substituent on the amidic nitrogen, gave two 
exo-methylenic products 23c and 24c (entries 9-10) when the cyclization reaction was crried out in 
toluene. 
Finally, when 20d underwent AuCl3-catalyzed cyclization in the same solvent at 50°C for 1 hour, 
only 21d together with the exo-methylenic regioisomer 23d and the product 25d lacking in the 
benzoyl group were obtained. 
These outcomes reveal that in all cases, as for products 17b and 18b, the HPLC-MS ratio between 
the different products is strictly dependent on the reaction solvent. In fact, in reactions employing 
20a and 20b, shifting from unpolar solvents to more polar ones ( ntries 1-3 and analogously entries 
4-6 and 7-8), the HPLC-MS ratio between 21a,b and 22a,b slowly decreased. The same behaviour 
was observed starting from 21c between the two exo-methylenic regioisomers 23c and 24c (entries 
9-10), and carrying out the reaction in dichloromethane at reflux for 1 hour afforded also the 
cyclized rearranged product 26c. Even more, this latter was the only one detected in the most polar 
solvent (entry 11). 
Carrying out the reaction in dichloromethane at reflux for 1 hour provided also the cyclized 
rearranged product 26c (entry 10), lacking in the amidic nitrogen substituent, even if in low yield. 
Varying the solvent in 20d, at last, drove the cyclization completely to the rearranged product 22d, 
not observed in toluene. 
In DMF instead regioisomers 25d and 26d, lacking in the benzoyl group, were obtained in almost 





2.13 Synthesis of propargylamides 20e-g 
N-Substituted-propargylamides bearing a phenyl substit ent at the acetylenic carbon were 
synthesized. Propargylamides 20e and 20g were obtained in excellent yields by reaction of 15b and 












Propargylamide 20f was obtained starting from the reaction between the carboxylic acid 15b, that 
was transformed in the corresponding acylchloride using oxalylchloride, and the amide 2f. As for 
the amide 2d, also in this case deprotonation of the amidic proton by NaH was necessary to increase 


































15b 20e (90%)2e : R2 = Me





















2.14 Gold catalyzed cyclizations of N-substituted-carboxamides 20e-g 
 
We extended then AuCl3 catalyzed cyclization on different solvents to N-substituted-
proparglylamides 20e-g bearing a phenyl substituent at the acetylenic carbon. Results are shown in 
Table 9. 
 































Compared to substrates 20a-d, that gave only six-membered cyclized products (Table 9), substrates 
20e-g yielded only seven-membered cyclized products in the reaction catalyzed by AuCl3. 





      27:28 27 28 
1 20e Me DCM reflux 8 1:3 20 63 
2 20e Me MeCN reflux 2 1.5:1 43 31 
3 20e Me DMF 90 24 5:1 66 12 
4 20f Ts DCM rt 0.5 1:2.8 20 60 
5 20f Ts MeCN 40 0.25 3:1 55 17 
6 20f Ts DMF 90 24 10:1 68 7 
7 20g Bn Toluene 80 6 1:5 14 72 
8 20g Bn DCM reflux 5 1:6 12 74 
9 20g Bn MeCN reflux 0.5 1:2.5 23 67 
10 20g Bn DMF 90 24 5:1 66 14 






















No other products were detected in all solvents used. The formation of the seven-membered 
cyclized products can be found in a stabilizing effect of the phenyl group in the transition state of 
the reaction. 
In addition, Table 9 shows that the HPLC-MS ratio between cyclized products 27e-g and cyclized 
rearranged products 28e-g varied once again passing from less polar to more polar reaction 
solvents. However, this behaviour is in this case opposite to that observed in Table 8 for six-
membered cyclized products, where the HPLC-MS ratio sh fted in favour of unrearranged cyclized 
products decreasing the polarity of the reaction solvent. 
 
2.15 Hypothesis of reaction mechanism for the formation of substrates 20a-d and 20e-g 
A proposed mechanism for the hydroarylation of alkynes with pyrroles (substrates 20a-d) is shown 
in Figures 4 and 5. 
 
 

























































20a: R2 = Bn,  R3= H
20b:  R2 = Ts,   R3= H
20c:  R2 = Boc, R3= H




 Figure 5. Proposed reaction mechanism for substrates 20a-d (C talytic Cycles 2) 
 
In the catalytic cycle 1 the alkyne is activated by coordination to AuCl3 (A) and undergoes 
electrophilic aromatic substitution by pyrrolic C-3 to give the vinyl-gold complex (B) or the 
protoisomer (C) depending on the reaction condition. Cleavage of the gold-carbon bond in both 
complexes by pyrrolic proton at C-3 resulted respectiv ly in 21a-d and 23a-d. 
 
The catalytic cycle 2 shows the same complex (A), described in catalytic cycle 1, which undergoes 
electrophilic aromatic substitution with the pyrrole at C-2 to give the vinyl-gold complex (E) and 
the protoisomer (F) depending on the reaction conditions. Both of these complexes have an instable 
spirostructure and so they undergo a 2,3-migration of the amide moiety giving respectively the 
gold-complex (G) and (H) that are protonated by pyrrolic proton at C-3 affording the cyclized 














































































20a: R2 = Bn,  R3= H
20b:  R2 = Ts,   R3= H
20c:  R2 = Boc, R3= H
20d:  R2 = Bz,  R3 = H
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To explain the hydroarylation of alkynes with pyrrole for substrates 20e-g, that gave only seven-
membered cyclized products, a similar mechanism was proposed as depicted in Figures 6 and 7. 
In the catalytic cycle 3 the alkyne is activated by coordination to AuCl3 (A) and undergoes 
electrophilic aromatic substitution with pyrrole atC-3 to give the seven-membered vinyl-gold 
complex (I ) and the protoisomer (L ). The following cleavage of the gold-carbon bond i the 
complex (I ) by pyrrolic proton at C-3 affords products 27e-g and regenerates the gold catalyst. No 




















































20e: R2= Me, R3= Ph
20f:   R2=Bn, R3= Ph





Figure 7. Proposed reaction mechanism for substrates 20e-g (Catalytic Cycles 4) 
                        
The catalytic cycle 4 shows the same complex (A), described in catalytic cycle 3 that undergoes 
electrophilic aromatic substitution with the pyrrole at C-2 to give the seven membered vinyl-gold 
complexes (M ) and (F). Both of these complexes have an instable spirostructure and so they 
undergo a 2,3-migration of the amide moiety giving respectively the gold-complex (O) and (P). 
Only vinyl-gold complex (O) is protonated by pyrrolic proton at C-3 producing the cyclized 






































































20e: R2= Me, R3= Ph
20f:   R2=Bn, R3= Ph
20g:  R2=Ts, R3= Ph
40 
 
2.16 Gold catalyzed intramolecular hydroalkoxylation of C-C triple bonds. 
Traditional methodologies for the synthesis of a number of heterocycles like benzofurans,66 
benzothiophenes,67 isoquinolines,68 indoles, 69 isocumarin,70 isoindolinones,71 and other polycyclic  
aromatics72 are based on the electrophilic  cyclization of appro riate functionally-substituted 
alkynes using iodine, bromine, sulphur and selenium containing electrophiles. 
These methodologies show many limitations with regad to atom efficiency and waste formation 
and in some cases required the remotion of the electrophile used from the molecule skeleton. These 
and other reasons have stimulated considerable interest in developing new, efficient homogeneous 
catalytic methods for the synthesis of heterocyclic ompounds.73 
Intramolecular catalytic hydroalkoxylation, the addition of a hydroxyl group to an insatured carbon-
carbon bond, is a simple, straightforward and atom-economical route to construct carbon-oxygen 
bonds creating to huge number of oxygen containing heterocycles that are important structural 
components of many naturally occurring and pharmacologically active molecules.74 
Despite the recent progress of hydroalkoxylation based on transition metal catalysts,75,76 efficient 
catalytic transformations remain a challenge due to relatively high enthalpies of typical O-H δ-
bonds and low reactivity of electron-rich olefins with nucleophiles. 
In this context homogenous gold catalysis has emerged in organic synthesis as a powerful tool due 
to its unique ability to activate carbon-carbon bonds toward the attack of many nucleophiles.77 In 
particular gold catalyzed intramolecular hydroalkoxylation of alkynes represents a fruitful route for 
the synthesis of oxygenated heterocycles compounds.78 
As part of our continuing interest on gold catalysis, we were intrigued to investigate the gold 
catalyzed intramolecular hydroalkoxylation of alkynes tethered with variously 2-substituted amino 
phenols in order to i) develop a different catalytic approach for the synthesis of oxygen-containing 
heterocycles, ii) verify the feasibility of the gold-catalyzed intramolecular hydroalkoxylation of 













R : = H, Alkyl
33 : X = O
X= NH, NR,
34 : X = O
R : = H, Alkyl
In this section we report our results concerning the gold-catalyzed intramolecular hydroalkoxylation 
of 2-substituted-(prop-2-yn-1-ylamino)phenols 31 and 2-(prop-2-yn-1-yloxy)phenol 33 leading 
respectively to variously substituted 2,3-dihydro-2-methylene-1,4-benzoxazine 32 and -1,4 










The 1,4-benzoxazines and benzodioxins structure are an integral part of several naturally occurring 
substances,79 moreover benzoxazines derivates have been shown to have interesting 
pharmacological properties.80 
To the best of our knowledge only one paper dealing with metal catalyzed intramolecular synthesis 




























2.17 Synthesis of 2-(prop-2-yn-1-ylamino)phenol 31a 
The 2-(prop-2-yn-1-ylamino)phenol 31a, was prepared from the reaction between 2-aminophenol 
29 and propargyl bromide 30 in ethanol at room temperature for 48 hours. 
 The solvent was then evaporated and the residue was dissolved in TBME, filtered to remove the 
excess of starting material 31a and then the solvent was evaporated again to give a crude residue 











2.18 Optimization of gold catalyzed cyclization conditions on 2-(prop-2-yn-1-ylamino)phenol 
31a  
Reaction conditions were optimized by using various A (I) and Au(III) catalysts in the reaction of 











Table 10. Optimization of reaction conditions 
aAu-catalyst is used in 5 mol% 
bK2CO3 used in 10% mol  







                                                                   Figure 8. 8-Hydroxyquinoline 
 
Entry Catalytic systema Cocatalystb Solvent Reaction products (%)c 
    31a 32a 35a 
1 AuCl3 - MeCN 90 - 10 
2 AuCl3, AgBF4 - MeCN 85 - 15 
3 AuCl3, AgOTf - MeCN 80 - 20 
4 AuCl3 - CH2Cl2 100 - - 
5 AuCl3, AgBF4 - CH2Cl2 100 - - 
6 AuCl3, AgOTf - CH2Cl2 100 - - 
7 NaAuCl4·2H2O - MeCN 20 - 80 
8 AuCl - MeCN 100 - - 
9 AuCl - dioxane 100 - - 
10 PPh3AuCl, AgOTf - CH2Cl2 100 - - 
11 PPh3AuCl, AgOTf - MeCN 100 - - 
12 PPh3AuCl, AgBF4 - MeCN 100 - - 
13 AuI - MeCN 100 - - 
14 AuCl K2CO3 MeCN - 90 10 
15 PPh3AuCl, AgBF4 K2CO3 MeCN 60 40 - 
16 PPh3AuCl, AgOTf K2CO3 MeCN 55 45 - 
17 NaAuCl4·2H2O K2CO3 MeCN 35 35 30 
18 AuCl3 K2CO3 MeCN 60 20 20 
19 AuCl3, AgBF4 K2CO3 MeCN 55 25 20 
20 - K2CO3 MeCN 100 - - 
44 
 
Treatment of 2- (prop-2-yn-1-ylamino)phenol 31a with AuCl3,alone or in addition to AgBF4 and 
AgOTf, in acetonitrile, at reflux resulted in the rcovery of starting material 31a together with the 
formation 6-endo-dig-cyclized product 35a (Figure 8) although in very low yield (entries 1-3). 
When the same catalytic systems were used in dichloromethane as solvent no cyclization product 
was observed (Entries 4-6). 
To our surprise, the use of NaAuCl4 in acetonitrile instead of AuCl3 afforded the 8-
hydroxyquinoline 35a in high yields (entry 7). 
By performing the reaction with the presence of Au(I)-salts in different solvents no trace of cyclized 
products 32a and 35a were detected (entry 8-13). 
Working with the presence of AuCl (5 mol %) and K2CO3 (10 mol %) as a co-catalyst in 
acetonitrile at reflux  the desidered 6-exo-dig-1,4-benzoxazine 32a was obtained in satisfactory 
yield with only a very small amount of 35a (Entry 14). 
To test the effectiveness of K2CO3 as a co-catalyst we tried it in reaction with others Au(I) catalytic 
systems but lower yield of compound 32a were observed (entries 15-16). 
The use of K2CO3 (10% mol) with Au(III)-catalysts alone or in the presence of silver salts seems to 
afford 32a in lower yield increasing the amount of 35a (entries 17-19). 
To rule out the hypothesis that K2CO3 was responsible for the formation of 32a in absence of any 
type of gold catalyst, 31a was heated in acetonitrile at reflux for 24h with a 10% mol of K2CO3 
recoverying only starting material.  
 
2.19 Synthesis of 8-hydroxyquinoline 35a 
With the optimized conditions at hand we tried to reproduce the reaction of formation of 35a in a 
bigger scale. NaAuCl4 (5% mol) was added to a solution of 31a in acetonitrile dry. The mixture was 
refluxed for 24 hours then solvent was evaporated to ryness. The crude was purified by flash 

































2.20 Synthesis of 2,3-dihydro-2-methylene-1,4-benzoxazine 32a 
The scale-up of the formation of 32a required the use of optimized conditions of Table 12 (entry 
14). To a solution of 31a in acetonitrile at room temperature K2CO3 (10 % mol) and AuCl (5 % 
mol) were added. The mixture obtained was stirred at reflux for 8h, and then the solvent was 














































The cyclization ran in the 5-exo-methylenic manner leading to the 2,3-dihydro-2-methylene-1,4-
benzoxazine 32a in 70% yield in addition to a 10% of the regioisomer 35a arising from a 6-endo-
dig-hydroarylation process. 
The structure of the two regioisomeric compounds 32a and 35a was unequivocally assigned by 1H
NMR. In particular 1H NMR δ chemical shift of the two alkylic protons Ha on carbon C1 in 32a is 
different from that of Ha’ on the same carbon C1 in 35a. The same happened for 
1H NMR chemical 
shifts δ of aromatic protons Hb’ and Hc’ respectively on C2 and C3 carbons in 35a that are 
completely different from the ones observed for vinylic proton Hb and Hc on C3 in 32a. The 5-exo 
dig cyclization way observed in 32a was confirmed by 1H NMR, 13C NMR and edited gHSQC that 























2.21 Synthesis of 2-substitued (prop-2-yn-1-ylamino)phenols 31b-d 
 
To explore the scope of the gold catalyzed cyclization under the conditions of entry 14 of Table 12 
we decided to prepare others 2-(prop-2-yn-1-ylamino)phenols but with a substituent on the free 












31b : R1 = Bz
31c : R1 = Ac
31d:  R1 = Ts
(Table 11) by the reaction between 31a and the corresponding acylating agent, in dichloromethane 
as solvent, at room temperature and in the presence of an excess of pyridine. 
 
                        Table 11. Reaction yields of 31a with same acylating agents R1Cl                                  






























2.22 Synthesis of 2-substituted (prop-2-yn-1-ylamino)phenols 31e-g 
 
Different synthetic approaches were adopted for the preparation of 2-substitued (prop-2-yn-1-
ylamino)phenols 31e-g. The substrate 31e was synthesized in three steps by reaction between the 2-
aminophenol 29 and BzCl to give the compound 36 followed by reduction of the amide moiety with 
BH3.THF complex. The intermediate 37 so obtained was then alkylated on the nitrogen with 
propargylbromide (Scheme 40).The total yield of the process was 70%. 
 
 












































DCM, 00C to rt, 2h




















The synthesis of 31e and 31f required the formation of the corresponding intermediates 38a and 
38b, obtained by reaction of 31a with the alkynes 30a and 30b, which were then acylated on the 
nitrogen using benzoylchloride and tosylchloride respectively. Total yield for 31e was 50% whereas 
































AuCl (5% mol), K2CO3 (10% mol)
MeCN, rfx
2.23 Synthesis of 2,3-dihydro-2-methylene-1,4-benzoxazines 31b-f by gold catalysis 
The substrates 31b-f were submitted to the gold-catalyzed cyclization under conditions used for the 
synthesis of 32a (Scheme 38) and the results are presented in Table 12. 
 








































Entry Substrate R1 R2 Time (h) Yields of products (%) 
1[a] 31a H H 8  
2 31b Bz H 8  
3 31c Ac H 5  
4 31d Ts H 1  
5 31e Bn H 5  
6[b],[c] 31f Bz Me 2  
7[b],[c],[d] 31g Ts Ph 24  
 
 
[a] After chromatographyc column 10% of  35a was  isolated 
[b] AuCl3 (5% mol) was used instead of AuCl 
[c] DMF used as solvent at  95oC 









































The reactions were completed in 1-24 h, providing the 5-exo-methylene-2,3-dihydro-1,4-
benzoxazines in a range of yields between 30 and 90%. Only 2-(prop-2-yn-1-ylamino)phenols 31a, 
having a free N-H, afforded the cyclized product 32a in 70% yield in addition to a 10% of 
regioisomer 8-hydroxyquinoline 35a. 
The presence respectively of a benzoyl and acetyl group on the nitrogen of phenol-acetylenes 31b 
and 31c led smoothly to the same yields of the corresponding cyclized products. The compound 
31d, bearing a tosyl-group on the nitrogen, gave rise to the fastest rate and highest yield of 
cyclization. The increase of the nitrogen nucleophilicity in 31e, using a benzyl group, seemed not to 
change the reaction course giving a 65% yield of the corresponding 1,4-benzoxazine without other 
side-products. Inertness of substrates 31f and 31g, carrying respectively a phenyl and a methyl 
group on the acetylenic carbon and a tosyl and benzoyl group on the nitrogen, to react under the 
conditions used for other compounds 31a-d, prompted us to examine different ways to drive th 
cyclization. After a short screening of gold catalysts and solvents, we noticed that the use of AuCl3 
instead of AuCl was effective to perform the heterocyclization reaction with these substrates only in 
DMF at 95oC. Under these new conditions compounds 31f led to a clear mixture of cis and trans 
2,3-dihydro-1,4-benzoxazines, in good yields and with the cis isomer as the major product. The 
behaviour of 31g was surprisingly different from 31f resulting in a tarry mixture that provided only 
the cis-disteroisomer in 35% yield in addition to a 5% of the highly conjugate cis-35c lacking in the 
tosyl group and with an iminic-double bond. The absolute stereochemistry of the cis-diasteroisomer 
32f as well as of cis-32fg and cis-35c were assigned by NOE measurements. The stereochemistry of 
the trans diasteroisomers 32g was assigned only on the basis of the different 1H NMR and 13C 
NMR chemical shifts from those of the cis-diasteroisomer, because of the very broad resonance of 















































Figure 10. NOE enhacements observed in cis-isomers of compounds 32f-g and 35c 
 
2.24 Synthesis of 2-(prop-2-yn-1-yloxy)phenol 41 and 3-(prop-2-yn-1-yloxy)naphthalen-2-ol 42 
We decided to extend the scope of the reaction to other heterocycles containing the same type of 
heteroatoms. To do that we prepared the compounds 41 and 42 by reaction of benzene-1,2-diol 39 

















      












4341 AuCl (5% mol), K2CO3 (10% mol)
MeCN, rfx
42 44
2.25 Synthesis of 2-methylidene-2,3-dihydro-1,4-benzodioxines 43 and 44 by gold catalysis 
The compounds 41 and 42 were submitted to the gold catalysis under the previous conditions used 
for the synthesis of 1,4-benzoxazines 32a-g (Table 13). 
 


















As for substrates 31a-g, the gold catalyzed cyclization on compounds 41 and 42 ran only in 5-exo-
methylenic way as confirmed by 1HNMR, 13C NMR and edited gHSQC experiments on cyclized 
products 43 and 44. 
Substrate 41 smoothly cyclized, in refluxing acetonitrile, to the corresponding 1,4-benzodioxine in 
70% yield in 7 hours. Compounds 42 didn’t afford the cyclization product 44 under the conditions 
Entry Substrate Time (h) Yields of products (%) 
1 41 7 43 (70%) 
2[a] 42 1.5 44 (75%) 
[a] Reaction performed in DMF at 100oC 
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used for 41, so it was necessary to investigate different solvents to find out that only DMF at 100oC 
was able to give quickly the desired cyclization in good yield.  
 
2.26 Hypothesis of reaction mechanism for the formation of 1,4 benzoxazines 32a-g and 1,4-
benzodioxines 43 and 44 
 
A proposed mechanism for the gold catalyzed heterocyclization is shown in Figure 11. 
 
 




The C-C triple bond of the propargylic moiety is activated by the coordination of both Au(I) and 
Au(III) species (intermediate A). The so generated π-alkyne complex undergoes intramolecular 
nucleophilic attack by the hydroxyl group on the benz ne ring affording a protonated intermediates 
B that evolved to the next intermediate C by deprotonation with a catalytic amount of K2CO3. It’s 





























31a-g and/ or 41-42
X= NH, NR, O
R= H, Me, Ph
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Protonolysis of the gold-carbon bond of C by KHCO3 give rise to the 1,4-benzoxazines 32a-g and 




























To summarise, new synthetic approaches based on gold catalysis have been developed.  
Allenamides were proven to be efficient substrates for gold-catalyzed cyclization, increasing the 
range of synthetic applications. The procedure generated represents the first example of a gold-
catalyzed cyclization on allenes bearing an amido group which, however resulted as inactive. 
Moreover the obtained oxazolidinones bear a useful vinyl group in position 2 that allow further 
functionalization in order to investigate their potential effectiveness as organocatalysts. 
The intramolecular hydroarylation of N-alkynyl pyrrolo-2-carboxamides was accomplished by gold 
(III)-catalysis giving bicyclic pyrrolo-fused products. The outcome of the reaction led to differently 
substituted pyrrolo-pyridines and pyrrolo-azepines ari ing either from direct cyclization or from a 
formal rearrangement of the carboxamides group. While t e substrates having a monosubstituted 
acetylene afforded pyrrolo[2,3-c]pyridine and pyrrolo[3,2-c]pyridine structures, the N-substituted 
propargylamides bearing a phenyl substituent at the ac tylenic carbon furnished pyrrolo[2,3-
c]azepines and pyrrolo[3,2-c]azepines by a 7-endo-dig cyclization products. 
Finally a valuable intramolecular gold catalyzed heterocyclization process on 2-substitued (prop-2-
yn-1-ylamino)phenols and 2-(prop-2-yn-1-yloxy)phenols was achieved affording 2,3-dihydro-1,4-
benzoxazines and 1,4-benzodioxines in good yields and with an excellent regioselectivity with 
formation of only exo-methylenic cyclized products. The presence of an exo-vinyl double bond 










Melting points were measured with a Büchi B-540 heating unit and are uncorrected. IR spectra were 
recorded on a FT-IR spectrophotometer. Optical rotations were measured on a Jasco P-1010 
polarimeter. Some 1H NMR and 13C NMR spectra were recorded at 400 and 100 MHz on an 
AVANCE 400 Bruker, other at 600 MHz on a INOVA AS600 Variant. Chemical shifts (δ) are 
given as ppm relative to the residual solvent peak (chloroform-d1 7.25 ppm/77 ppm). Mass spectra 
were determined on an HPLC-MS LCQ-Advantage Thermo Finnigan instrument. Some protonated 
molecular mass ion peaks were determined on an HPLC-MS Agilent Technologies 6140 (ESI). 
Elemental analyses were executed on Perkin-Elmer CHN Analyzer Series II 2400. Column 
chromatography was performed on a Merck silica gel 60, (mesh size 63-200 µm).  
General procedure for the preparation of propargylamides 3a-f 
DCC (10 mmol), 2a (8.3 mmol) and DMAP (0.125 mmol) in anhydrous CH2 l2 (60 mL), cooled at 
0 °C, were slowly added to a solution of 1 (10 mmol). The resulting solution was stirred at r.t. for 
48 h, then filtered on a path of silica gel. The solvent was evaporated under reduced pressure and 
the crude residue was purified by flash chromatography (light petroleum / AcOEt 7:3).  
(S)-2-(t-Butoxycarbonylamino)-3-methyl-N-methyl-N-propargylbutanamide (3a) 
Yield: 95%. Colourless oil. IR (nujol): 3304, 3298, 2119, 1703, 1651 cm-1; [α]23D = +29.5 (c = 0.80, 
CHCl3); Rotamers ratio 2.5:1; 
1H NMR (400 MHz, CDCl3, T = 25°C) δ: 0.92 (3H, d, J = 6.6 Hz), 
0.99 (3H, d, J = 6.6 Hz), 1.45 (9H, s), 1.90-2.05 (1H, m), 2.24 (1H, d, J = 2.3 Hz), 2.93 (3H, s), 
3.75-3.85 (1H, m), 4.15-4.30 (2H, m), 5.33 (1H, d, J = 8.9 Hz) (major rotamer); 0.66 (3H, d, J = 6.7 
Hz), 0.72 (3H, d, J = 6.7 Hz), 1.18 (9H, s), 1.70-1.80 (1H, m), 2.22 (1H, d, J = 2.3 Hz), 2.76 (3H, 
s), 3.75-3.85 (1H, m), 4.15-4.30 (2H, m), 5.33 (1H, d, J = 8.9 Hz) (minor rotamer); 13C NMR (100 
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MHz, CDCl3, T = 25°C) δ: 17.6 (q), 19.5 (q), 28.5 (q), 31.5 (d), 34.7 (q), 36.7 (t), 55.2 (d), 72.6 (d), 
78.5 (s), 79.3 (s), 156.0 (s), 172.3 (s) (major rotamer); 17.7 (q), 19.8 (q), 28.5 (q), 31.4 (d), 34.7 (q), 
39.5 (t), 55.4 (d), 73.6 (d), 78.5 (s), 79.4 (s), 155.9 (s), 172.4 (s) (minor rotamer). MS: m/z 268 
(M+). Anal. calcd for C14H24N2O3: C, 62.66; H, 9.01; N, 10.  
(S)-2-(t-Butoxycarbonylamino)-N-methyl-N-propargylpropanamide (3b) 
Yield: 96 %. Colourless oil. IR: 3306, 3291, 2122, 1705, 1649 cm-1; [α]23D = +9.7 (c = 1.13, 
CHCl3); Rotamers ratio 2.3:1; 
1H NMR (400 MHz, CDCl3, T = 25°C) δ: 1.33 (3H, d, J = 7.2 Hz), 
1.45 (9H, s), 2.24 (1H, d, J = 2.0 Hz), 3.15 (3H, s), 4.20 (1H, d, J = 17.0 Hz), 4.37 (1H, d, J = 17.0 
Hz), 4.64 (1H, dq, J = 7.2, 7.2 Hz), 5.48 (1H, d, J = 7.2 Hz) (major rotamer); 1.37 (3H, d, J = 7.2 
Hz), 1.45 (9H, s), 2.34 (1H, d, J = 2.0 Hz), 3.04 (3H, s), 3.96 (1H, d, J = 17.0 Hz), 4.40 (1H, d, J = 
17.0 Hz), 4.64 (1H, dq, J = 7.2, 7.2 Hz), 5.41 (1H, d, J = 7.2 Hz) (minor rotamer); 13C NMR (100 
MHz, CDCl3, T = 25°C) δ: 19.1 (q),28.7 (q), 34.5 (d), 37.1 (t), 46.8 (q), 72.7 (d), 77.8 (s), 79.4 (s), 
155.6 (s), 173.1 (s) (major rotamer); 19.5 (q), 28.7 (q), 34.5 (d), 39.5 (t), 46.8 (q), 73.6 (d), 77.8 (s), 
79.4 (s), 155.6 (s), 173.1 (s) (minor rotamer). MS: m/z 240 (M+). Anal. calcd for C12H20N2O3: C, 
59.98; H, 8.39; N, 11.66. Found C, 60.11; H, 8.22; N, 11.43.44. Found C, 62.41; H, 9.18; N, 10.60.  
(S)-2-(t-Butoxycarbonylamino)-N-methyl-3-phenyl-N-propargylpropanamide (3c) 
Yield: 94%. Colourless oil. IR: 3306, 3295, 2121, 1705, 1650 cm-1; [α]23D = +38.8 (c = 0.40, 
CHCl3); Rotamers ratio 3:1; 
1H NMR (400 MHz, CDCl3, T = 25°C) δ: 1.43 (9H, s), 2.22 (1H, d, J = 
2.4 Hz), 2.73 (3H, s), 2.80-3.20 (2H, m), 4.02 (1H, d, J = 17.2 Hz), 4.21 (1H, d, J = 17.2 Hz), 4.80-
4.85 (1H, m), 5.41 (1H, d, J = 7.9 Hz), 7.19-7.30 (5H, m) (major rotamer); 1.41 (9H, s), 2.27 (1H, 
d, J = 2.4 Hz), 2.80-3.20 (5H, m), 3.82 (1H, d, J = 17.2 Hz), 3.97 (1H, d, J = 17.2 Hz), 4.80-4.85 
(1H, m), 5.30-5.40 (1H, m), 7.19-7.30 (5H, m) (minor r tamer); 13C NMR (100 MHz, CDCl3, T = 
25°C) δ: 28.7 (q), 34.4 (q), 36.9 (t), 40.4 (t), 51.9 (d), 72.6 (d), 78.4 (s), 80.0 (s), 127.3 (d), 128.8 
(d), 129.9 (d), 136.6 (s), 155.4 (s), 171.8 (s) (major rotamer); 28.7 (q), 33.8 (q), 39.4 (t), 40.0 (t),
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51.9 (d), 73.7 (d), 78.4 (s), 80.2 (s), 127.3 (d), 129.0 (d), 129.6 (d), 136.9 (s), 155.4 (s), 171.8 (s) 
(minor rotamer). MS: m/z 316 (M+). Anal. calcd for C18H24N2O3: C, 68.33; H, 7.65; N, 8.85. Found 
C, 68.42; H, 7.50; N, 8.89. 
(S)-2-(t-Butoxycarbonylamino)-N-methyl-3,3-dimethyl-N-propargylbutanamide (3d) 
Yield:  90%. Colourless oil. Rotamers ratio 3:1; 1H NMR (400 MHz, CDCl3, T = 25°C) δ: 0.99 (9H, 
s), 1.43 (9H, s), 2.21 (1H, dd, J = 2.5, 2.5 Hz), 3.21 (3H, s), 3.97 (1H, dd, J = 17.2, 2.3 Hz), 4.50 
(2H, m), 5.30 (1H, d, J = 10 Hz), (major rotamer); 1.02 (9H, s), 1.43 (9H, s), 2.32 (1H, dd, J = 2.3, 
2.3 Hz), 3.01 (3H, s), 4.11 (1H, dd, J = 18.5, 2.1 Hz), 4.50 (2H, m), 5.30 (1H, br.s.), (minor 
rotamer); 13C NMR (100 MHz, CDCl3, T = 25°C) δ: 26.3 (q), 26.9 (s), 28.3 (q), 36.1 (q), 36.4 (q), 
55.9 (d), 71.9 (d), 78.3 (s), 79.5 (s), 155.6 (s), 171.7 (s) (major rotamer); 26.4 (q), 26.9 (s), 28.3 (q), 
33.1 (q), 40.0 (t), 55.9 (d), 73.1 (d), 78.3 (s), 79.5 (s), 155.6 (s), 171.7 (s) (minor rotamer). HPLC-
MS (ESI): m/z 283.38 (MH+).  
(S)-2-(t-Butoxycarbonylamino)-N-methyl-N-propargylbutanamide (3e) 
Yield: 85%. Colourless oil. Rotamers ratio 1.2:1; 1H NMR (400 MHz, CDCl3, T = 25°C) δ: 0.96 
(3H, dd, J = 7.4, 7.4 Hz), 1.46 (9H, s), 1.60 (1H, m), 1.78 (1H, m)  2.25 (1H, dd, J = 2.3, 2.3 Hz), 
3.17 (3H, s), 4.13 (1H, dd, J = 17.1, 2.9 Hz), 4.36 (1H, dd, J = 17.1, 2.3 Hz), 5.39 (1H, d, J = 7.8 
Hz), (major rotamer); 0.96 (3H, m), 1.46 (9H, s), 1.60 (1H, m), 1.78 (1H, m) 2.33 (1H, dd, J = 2.3, 
2.3 Hz), 3.04 (3H, s), 4.0 (1H, dd, J = 18.1, 2.1 Hz), 4.42 (1H, m), 5.32 (1H, d, J = 7.0 Hz), (minor 
rotamer); 13C NMR (100 MHz, CDCl3, T = 25°) δ: 9.5 (q),26.3 (t), 28.3 (q), 34.3 (q), 36.6 (t), 51.3 
(d), 72.1 (d), 78.2 (s), 79.5 (s), 155.5 (s), 172.0 (s) (major rotamer); 9.6 (q), 26.4 (t), 28.3 (q), 34.3 
(q), 36.6 (t), 51.3 (d), 73.1 (d), 78.2 (s), 79.5 (s), 155.5 (s), 172.1 (s) (minor rotamer). HPLC-MS 





Yield: 97%. White solid. M. p. 78-80 °C. IR: 3306, 3289, 2115, 1710, 1648 cm-1; [α]23D = +152.2 (c 
= 0.94, CHCl3); Rotamers ratio 2.7:1; 
1H NMR (400 MHz, CDCl3, T = 25°C) δ: 1.43 (9H, s), 2.22 
(1H, d, J = 2.5 Hz), 2.95 (3H, s), 4.15-4.40 (2H, m), 5.58 (1H, d, J = 7.9 Hz), 5.97 (1H, d, J = 7.9 
Hz), 7.30-7.40 (5H, m) (major rotamer); 1.42 (9H, s), 2.22 (1H, d, J = 2.5 Hz), 3.05 (3H, s), 3.82 
(1H, d, J = 17.5 Hz), 4.12 (1H, d, J = 17.5 Hz), 5.60-5.65 (1H, m), 6.00-6.05 (1H, m), 7.30-7.40 
(5H, m) (minor rotamer); 13C NMR (100 MHz, CDCl3, T = 25°C) δ: 28.7 (q), 34.6 (q), 37.4 (t), 55.7 
(d), 72.7 (d), 78.3 (s), 80.1 (s), 128.1 (d), 128.7 (d), 129.4 (d), 137.9 (s), 155.4 (s), 170.3 (s) (major 
rotamer); 28.7 (q), 34.0 (q), 39.3 (t), 55.d (q), 73.8 (d), 78.3 (s), 80.1 (s), 128.1 (d), 128.7 (d), 129.4 
(s), 137.9 (s), 155.4 (s), 170.3 (s) (minor rotamer). MS: m/z 302 (M+). Anal. calcd for C17H22N2O3: 
C, 67.53; H, 7.33; N, 9.26. Found C, 67.42; H, 7.50; N, 9.47.  
General procedure for the preparation of allenamides 4a-f 
t-BuOK (2.5 mmol) in THF (10 mL) was added to a soluti n of 3 (1 mmol). The resulting solution 
was stirred at r.t. for 1 min, then filtered on silica gel (AcOEt). The solvent was evaporated under 
reduced pressure and the residue was used without further purification for the next step. 
(S)-2-(t-Butoxycarbonylamino)-3-methyl-N-methyl-N-(1,2-propadienyl)butanamide (4a) 
Yield: 98%. Colourless oil. IR: 3301, 1947, 1719, 1648 cm-1; [α]23D = +55.4 (c = 0.94, CHCl3); 
Rotamers ratio 1.1:1; 1H NMR (400 MHz, CDCl3, T = 25°C) δ: 0.92 (3H, d, J = 6.8 Hz), 1.00 (3H, 
d, J = 6.8 Hz), 1.45 (9H, s), 1.90-2.10 (1H, m), 3.14 (3H, s), 4.50-4.65 (1H, m), 5.25-5.35 (1H, m), 
5.43 (2H, d, J = 6.4, Hz), 7.54 (1H, dd, J = 6.4, 6.4 Hz) (major rotamer); 0.90 (3H, d, J = 6.8 Hz), 
1.00 (3H, d, J = 6.8 Hz), 1.45 (9H, s), 1.90-2.10 (1H, m), 3.04 (3H, s), 4.50-4.65 (1H, m), 5.25-5.35 
(1H, m), 5.43 (2H, d, J = 6.4 Hz), 6.97 (1H, dd, J = 6.4, 6.4 Hz) (minor rotamer); 13C NMR (100 
MHz, CDCl3, T = 25°C) δ: 17.5 (q), 19.9 (q), 28.8 (q), 31.9 (q), 33.5 (d), 55.7 (d), 80.0 (s), 87.4 (t), 
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100.1 (d), 156.2 (s), 171.1 (s), 201.6 (s) (major rotamer); 17.6 (q), 20.0 (q), 28.8 (q), 31.9 (q), 33.5 
(d), 56.1 (d), 80.0 (s), 87.8 (t), 101.3 (d), 156.2 (s), 171.1 (s), 203.0 (s) (minor rotamer). MS: m/z
268 (M+). Anal. calcd for C14H24N2O3: C, 62.66; H, 9.01; N, 10.44. Found C, 62.37; H, 9.19; N, 
10.49. 
(S)-2-(t-Butoxycarbonylamino)-N-methyl-N-(1,2-propadienyl)propanamide (4b)  
Yield: 94%. Colourless oil. IR: 3306, 1940, 1705, 1649 cm-1; [α]23D = +54.5 (c = 1.80, CHCl3); 
Rotamers ratio 1.1:1; 1H NMR (400 MHz, CDCl3, T = 25°C) δ: 1.37 (3H, d, J = 5.7 Hz), 1.45 (9H, 
s), 3.11 (3H, s), 4.73 (1H, dq, J = 5.7, 5.7 Hz), 5.40-5.50 (3H, m), 7.49-7.52 (1H, m) (major 
rotamer); 1.35 (3H, d, J = 5.7 Hz), 1.45 (9H, s), 3.04 (3H, s), 4.73 (1H, dq J = 5.7, 5.7 Hz), 5.40-
5.50 (3H, m), 6.85-6.88 (1H, m) (minor rotamer); 13C NMR (100 MHz, CDCl3, T = 25°C) δ: 19.4 
(q), 28.7 (q), 31.9 (q), 47.3 (d), 79.9 (s), 87.8 (t), 100.1 (d), 155.5 (s), 171.5 (s), 201.6 (s) (major 
rotamer); 19.2 (q), 28.7 (q), 33.0 (q), 46.9 (d), 79.9 (s), 87.3 (t), 100.9 (d), 155.5 (s), 171.5 (s),
202.8 (s) (minor rotamer). MS: m/z 240 (M+). Anal. calcd for C12H20N2O3: C, 59.98; H, 8.39; N, 
11.66. Found C, 60.17; H, 8.12; N, 11.50. 
(S)-2-(t-Butoxycarbonylamino)-N-methyl-3-phenyl-N-(1,2-propadienyl)propanamide (4c) 
Yield: 95%. Yellow oil. IR: 3306, 1942, 1701, 1650 cm-1; [α]23D = +56.7 (c = 0.63, CHCl3); 
Rotamers ratio 1.4:1; 1H NMR (400 MHz, CDCl3, T = 25°C) δ: 1.36 (9H, s), 2.72 (3H, s), 2.90-3.06 
(2H, m), 4.83-4.90 (1H, m), 5.30 (2H, d, J = 6.3 Hz), 5.62-5.69 (1H, m), 7.08-7.35 (5H, m), 7.44 
(1H, dd, J = 6.3, 6.3 Hz)  (major rotamer); 1.36 (9H, s), 2.91 (3H, s), 2.90-3.06 (2H, m), 4.90-4.97 
(1H, m), 5.25 (2H, d, J = 6.3 Hz), 5.62-5.69 (1H, m), 6.79 (1H, dd, J = 6.3, 6.3 Hz), 7.08-7.35 (5H, 
m) (minor rotamer); 13C NMR (100 MHz, CDCl3, T = 25°C) δ: 28.7 (q), 33.0 (q), 40.2 (t), 52.6 (d), 
80.0 (s), 87.6 (t), 100.0 (d), 127.3 (d), 128.8 (d), 129.8 (d), 136.6 (s), 155.5 (s), 170.6 (s), 202.9 (s) 
(major rotamer); 28.7 (q), 32.0 (q), 39.8 (t), 52.2 (d), 80.0 (s), 87.0 (t), 100.9 (d), 127.1 (d), 128.7 
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(d), 129.8 (d), 136.6 (s), 155.5 (s), 170.4 (s), 201.7 (s) (minor rotamer). MS: m/z 316 (M+). Anal. 
calcd for C18H24N2O3: C, 68.33; H, 7.65; N, 8.85. Found C, 68.05; H, 7.82; N, 9.09.  
(S)-2-(t-Butoxycarbonylamino)-3,3-dimethyl-N-methyl-N-(1,2-propadienyl)butanamide (4d) 
Yield: 98%. Colourless oil. Rotamers ratio 1:1; 1H NMR (400 MHz, CDCl3, T = 25°C) δ: 1.01 (9H, 
s), 1.46 (9H, s), 3.05 (3H, s), 4.61 (1H, d, J = 9.9 Hz), 5.30-5.47 (3H, m), 7.57 (1H, dd, J = 6.4, 6.4 
Hz), (major rotamer); 1.01 (9H, s), 1.47 (9H, s), 3.19 (3H, s), 4.65 (1H, d, J =9.9 Hz), 5.30-5.47 
(3H, m), 7.12 (1H, dd, J = 6.0, 6.0 Hz), (minor rotamer); 13C NMR (100 MHz, CDCl3, T = 25°C) δ: 
26.3 (q), 26.3 (q), 26.3 (q), 28.3 (q), 28.3 (q), 28.3 (q), 30.3 (s), 31.4 (q), 56.7 (d), 79.6 (s), 87.2 (t), 
99.5 (d), 154.7 (s), 170.5 (s), 201.2 (s) (major rotamer); 26.3 (q), 26.3 (q), 26.3 (q), 28.3 (q), 28.3 
(q), 28.3 (q), 30.3 (s), 34.1 (q), 56.3 (d), 79.6 (s), 86.7 (t), 101.8 (d), 154.7 (s), 170.5 (s), 202.8 (s), 
(minor rotamer). HPLC-MS (ESI): m/z 283.38 (MH+).  
(S)-2-(t-Butoxycarbonylamino)-N-methyl-N-(1,2-propadienyl)butanamide (4e) 
Yield: 97%. Colourless oil. Rotamers ratio 1:1; 1H NMR (400 MHz, CDCl3, T = 25°C) δ: 0.97 (3H, 
dd, J = 13.0, 7.4 Hz), 1.47 (9H, s), 1.63 (1H, m), 1.83 (1H, m), 3.04 (3H, s), 4.65 (1H, m), 5.38 
(1H, m), 5.44 (2H, d, J = 6.4 Hz), 7.53 (1H, dd, J = 6.4, 6.4 Hz) (major rotamer); 0.97 (3H, dd, J = 
12.5, 7.4 Hz), 1.47 (9H, s), 1.63 (1H, m), 1.83 (1H, m), 3.13 (3H, s), 4.65 (1H, m), 5.38 (1H, m), 
5.44 (2H, d, J = 6.4 Hz), 6.93 (1H, dd, J = 6.0, 6.0 Hz) (minor rotamer); 13C NMR (150.81 MHz, 
CDCl3, T = 25°C) δ: 9.6 (q), 26.3 (t), 28.3 (q), 28.3 (q), 28.3 (q), 31.5 (q), 51.9 (d), 79.6 (s), 87.4 
(t), 79.6 (s), 87.4 (t), 99.6 (d), 155.5 (s), 170.6 (s), 202.4 (s) (major rotamer); 9.6 (q), 26.3 (t), 28.3 
(q), 28.3 (q), 28.3 (q), 32.8 (q), 51.6 (d), 79.6 (s), 56.3 (d), 79.6 (s), 86.9 (t), 100.6 (d), 155.5 (s),






Yield: 95%. Yellow oil. IR: 3306, 1946, 1704, 1644 cm-1; [α]23D = +51.3 (c = 0.89, CHCl3); 
Rotamers ratio 1.5:1; 1H NMR (400 MHz, CDCl3, T= 25°C) δ: 1.43 (9H, s), 2.91 (3H, s), 5.27-5.42 
(2H, m), 5.64 (1H, d, J = 8.0 Hz), 5.95 (1H, d, J = 8.0 Hz), 6.77 (1H, dd, J = 6.4, 6.4 Hz), 7.25-7.75 
(5H, m) (major rotamer); 1.43 (9H, s), 3.03 (3H, s), 5.27-5.42 (2H, m), 5.70 (1H, d, J = 8.0 Hz), 
5.95 (1H, dd, J = 8.0, 8.0 Hz), 7.25-7.75 (6H, m) (minor rotamer); 13C NMR (100 MHz, CDCl3, T = 
25°C) δ: 28.7 (q), 33.0 (q), 56.3 (d), 80.3 (s), 88.0 (t),100.7 (d), 128.1 (d), 128.8 (d), 129.5 (d), 
137.6 (s), 155.4 (s), 168.9 (s), 202.7 (s) (major rotamer); 28.7 (q), 32.2 (q), 55.8 (d), 80.3 (s), 87.3 
(t), 100.2 (d), 128.1 (d), 128.8 (d), 129.5 (d), 137.9 (s), 154.3 (s), 168.9 (s), 201.6 (s) (minor 
rotamer). MS: m/z 302 (M+). Anal. calcd for C17H22N2O3: C, 67.53; H, 7.33; N, 9.26. Found C, 
67.49; H, 7.61; N, 9.42.  
General procedure for cyclisation of allenamides 4a-f 
A 250 mL round bottomed flask fitted with a magnetic stirrer was charged with 4 (4.2 mmol ) and 
MeCN dry (75 mL) under argon atmosphere. AuCl3 (0.063 g, 0.21 mmol) weighted under argon 
atmosphere was added to the solution and the mixture was refluxed for 1-3.5h. After this time the 
mixture was cooled down to room temperature and concentrated in vacuo to dryness. Purification 
and separation of the two diasteromers by flash column chromatography (toluene / AcOEt 7:3) 
afforded 5-substituted (2S,5S) and (2S,5R)-3-methyl-1-terbutyloxycarbonyl-2-vinylimidazolidin-4-
ones 5. 
 tert-butyl (2R,5S)-2-ethenyl-3-methyl-4-oxo-5-(propan-2-yl)imidazolidine-1-carboxylate (cis-
5a) 
Pale yellow oil. IR (nujol): 1645,1706 cm-1. [α]23D = +52.3 (c = 0.69, CHCl3) 
 1H NMR (599.71 
MHz, CDCl3, T= 50°C) δ: 5.69 (ddd, 1H, J = 17.3, 9.9, 8.0 Hz), 5.50 (d, 1H, J = 17 Hz), 5.43 (d, 
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1H, J = 10.2 Hz), 5.16 (d, 1H, J = 7.7Hz), 4.05 (br.s. 1H), 2.79 (s, 3H), 2.23 (m, 1H), 1.46 (s, 9H), 
1.08  (d, 3H, J = 7.1 Hz), 1.01 (d, 3H, J = 7.1 Hz); 13C NMR (150.81 MHz, CDCl3, T= 50°C) δ 
169.5 (C),  154.1 (C), 135.1 (CH), 121.1 (CH2), 81.1 (C), 76.0 (CH), 64.0 (CH), 31.2 (CH3), 28.3 




Pale yellow oil. IR (nujol): 1648, 1714 cm-1 . [α]23D = +10.5 (c = 0.91, CHCl3) 
1H NMR (599.71 
MHz, CDCl3, T= 50°C) δ:  5.49 (m, 3H), 5.11 (m, 1H), 4.07 (m, 1H), 2.77 (s, 3H), 2.65 (1H, m), 
1.46 (s, 9H), 1.16 (d, 3H, J = 7.1 Hz), 0.86 (d, 3H, J = 6.9 Hz); 13C NMR (150.81 MHz, CDCl3, T= 
50°C) δ:  169.3 (C), 154.1(C), 135.8 (CH), 121.2 (CH2), 76.7 (CH), 63.2 (CH), 28.5 (CH3), 28.5 
(CH3), 28.5 (CH3), 26.6 (CH3), 18.5 (CH3), 16.3 (CH3). HPLC-MS (ESI): m/z 269.35 (MH+). 
tert-butyl (2R,5S)-2-ethenyl-3,5-dimethyl-4-oxoimidazolidine-1-carboxylate (cis-5b) 
1H NMR (599.71 MHz, CD3OD, T= 25°C) δ: 5.62 (m, 1H), 5.52 (d, 1H, J = 16.8 Hz), 5.46 (d, 1H, 
J = 9.9 Hz), 5.26 (d, 1H, J = 8.0 Hz), 4.13 (q, 1H, J = 6.8 Hz), 2.80 (s, 3H), 1.47 (s, 9H), 1.47 (d, 
3H, J = 6.6 Hz); 13C NMR (150.81 MHz, CD3OD , T= 50°C)  δ:  173.0 (C), 154.7 (C), 136.5 (CH), 
121.9 (CH2), 82.6 (C), 77.2 (CH), 56.2 (CH), 28.7 (CH3), 28.7 (CH3), 28.7 (CH3), 27.0 (CH3), 19.1 
(CH3). HPLC-MS (ESI): m/z 241.29 (MH
+). 
tert-butyl (2S,5S)-2-ethenyl-3,5-dimethyl-4-oxoimidazolidine-1-carboxylate (trans-5b) 
1H NMR (599.71 MHz, CD3OD, T= 25°C) δ:  5.62 (m, 1H), 5.51 (m, 2H), 5.24 (m 1H), 4.13 (m, 
1H), 2.78 (m, 3H), 1.47 (m, 12H); 13C NMR (150.81 MHz, CD3OD , T= 50°C) δ:  172.8 (C), 154.0 
(C), 136.0 (CH), 122.3 (CH2), 82.6 (C), 77.3 (CH), 55.5 (CH), 28.7 (CH3), 28.7 (CH3), 28.7 (CH3), 






tert-butyl (2R,5S)-5-benzyl-2-ethenyl-3-methyl-4-oxoimidazolidine-1-carboxylate (cis-5c) 
1H NMR (599.71 MHz, CD3OD, T= 50°C) δ  7.24 (m, 3H), 7.09 (m, 2H), 5.23 (d, 1H, J = 17.5 Hz), 
5.03 (d, 1H, J = 10.0 Hz), 5.00 (m, 1H), 4.38 (dd, 1H, J = 5.6, 2.5 Hz), 3.74 (m, 1H), 3.27 (m, 1H), 
3.15 (dd, 1H, J = 13.5, 2.0 Hz), 2.60 (s, 3H), 1.49 (br.s.,9H); 13C NMR (150.81 MHz, CD3OD , T= 
50°C)  δ  171.1 (C), 154.6 (C), 137.7 (C), 135.8 (CH), 131.4 (CH), 131.4 (CH), 129.4 (CH), 129.4 
(CH), 128.1 (CH), 121.9 (CH2), 82.6 (C), 77.7 (CH), 61.9 (CH), 37.0 (CH2), 28.8 (CH3), 28.8 
(CH3), 28.8 (CH3), 26.8 (CH3). HPLC-MS (ESI): m/z 317.39 (MH
+). 
tert-butyl (2R,5S)-5-tert-butyl-2-ethenyl-3-methyl-4-oxoimidazolidine-1-carboxylate (cis-5d) 
1H NMR (599.71 MHz, CD3OD, T= 25°C) δ: 5.82 (ddd, 1H, J = 17.0, 10.0, 7.9 Hz), 5.55 (d, 1H, J 
= 16.8 Hz), 5.48 (dt, 1H, J = 10.1, 0.9 Hz), 5.27 (d, 1H, J = 8.1 Hz), 3.98 (s, 1H), 2.78 (s, 3H), 1.48 
(s, 9H), 1.02 (s, 9H); 13C NMR (150.81 MHz, CD3OD , T= 25°C) δ:  171.3 (C), 157.1 (C), 136.0 
(CH), 122.3 (CH2), 82.7 (C), 78.1 (CH), 68.2 (CH), 36.5 (C), 28.6 (CH3), 28.6 (CH3), 28.6 (CH3), 
27.7 (CH3), 27.7 (CH3), 27.7 (CH3), 27.1 (CH3). HPLC-MS (ESI): m/z 283.37 (MH
+). 
tert-butyl (2S,5S)-5-tert-butyl-2-ethenyl-3-methyl-4-oxoimidazolidine-1-carboxylate ( trans-5d) 
1H NMR (599.71 MHz, CD3OD, T= 25°C) δ: 5.52 (m, 3H), 5.19 (dd, 1H, J = 7.7, 2.1 Hz), 4.06 (d, 
1H, J = 1.0 Hz), 2.72 (s, 3H), 1.45 (s, 9H), 1.00 (s, 9H); 13C NMR (150.81 MHz, CD3OD , T= 
25°C) δ:  171.2 (C), 155.2 (C), 137.1 (CH), 122.0 (CH2), 82.6 (C), 78.6 (CH), 66.8 (CH), 39.1 (C), 
28.6 (CH3), 28.6 (CH3), 28.6 (CH3), 27.2 (CH3), 27.2 (CH3), 27.2 (CH3), 26.9 (CH3). HPLC-MS 
(ESI): m/z 283.37 (MH+). 
tert-butyl (2R,5S)-2-ethenyl-5-ethyl-3-methyl-4-oxoimidazolidine-1-carboxylate (cis-5e) 
1H NMR (599.71 MHz, CD3OD, T= 25°C) δ:  5.64 (m, 1H), 5.54 (d, 1H, J = 17.0 Hz), 5.48 (d, 1H, 
J = 10.2 Hz), 5.27 (d, 1H, J = 8.2 Hz), 4.14 (dd, 1H, J = 5.2, 4.5 Hz), 2.79 (s, 3H), 1.95 (m, 1H), 
1.81 (m, 1H), 1.46 (s, 9H), 0.90 (t, 3H, J = 7.5 Hz); 13C NMR (150.81 MHz, CD3OD , T= 25°C) δ:  
171.9 (C), 155.0 (C), 136.1 (CH), 122.4 (CH2), 82.4 (C), 77.3 (CH), 61.3 (CH), 28.7 (CH3), 28.7 




tert-butyl (2S,5S)-2-ethenyl-5-ethyl-3-methyl-4-oxoimidazolidine-1-carboxylate (trans-5e) 
1H NMR (599.71 MHz, CD3OD, T= 25°C) δ:  5.58 (m, 3H), 5.23 (m, 1H), 4.20 (m, 1H), 2.79 (m, 
3H), 2.27 (m, 1H), 1.85 (m, 1H), 1.46 (m, 9H), 0.77 (m, 3H); 13C NMR (150.81 MHz, CD3OD , T= 
25°C) δ:  171.8 (C), 153.9 (C), 135.7 (CH), 122.6 (CH2), 82.5 (C), 78.0 (CH), 60.2 (CH), 28.7 
(CH3), 28.7 (CH3), 28.7 (CH3), 26.9 (CH3), 23.7 (CH2), 7.4 (CH3); HPLC-MS (ESI): m/z 255.32 
(MH+). 
tert-butyl (2R,5S)-2-ethenyl-3-methyl-4-oxo-5-phenylimidazolidine-1-carboxylate (cis-5f) 
1H NMR (599.71 MHz, CD3OD, T= 50°C) δ:  7.37 (m, 4H),  7.30 (m, 1H), 5.84 (ddd, 1H, J = 17.5, 
9.5, 7.9 Hz), 5.60 (d, 1H, J = 17.0 Hz), 5.54 (d, 1H, J = 10.0 Hz), 5.40 (d, 1H, J = 8.1 Hz), 5.13 (s, 
1H), 2.83 (s, 3H), 1.38 (br.s., 9H); 13C NMR (150.81 MHz, CD3OD , T= 50°C) δ:  170.5 (C), 154.8 
(C), 139.0 (C), 136.2 (CH), 129.5 (CH), 129.5 (CH), 129.1 (CH), 128.1 (CH), 128.1 (CH), 122.2 
(CH2), 82.7 (C), 77.3 (CH), 64.2 (CH), 28.6 (CH3), 28.6 (CH3), 28.6 (CH3), 27.4 (CH3). HPLC-MS 
(ESI): m/z 303.36 (MH+). 
tert-butyl (2S,5S)-2-ethenyl-3-methyl-4-oxo-5-phenylimidazolidine-1-carboxylate (trans-5f) 
1H NMR (599.71 MHz, CD3OD, T= 50°C) δ:  7.32 (m, 5H), 5.72 (m, 1H), 5.60 (m, 3H), 5.04 (m, 
1H), 2.86 (br.s., 3H), 1.40 (br.s., 9H); 13C NMR (150.81 MHz, CD3OD , T= 50°C) δ:  170.8 (C), 
154.9 (C), 140.8 (C), 135.2 (CH), 129.4 (CH), 129,4 (CH), 129.4 (CH), 128.0 (CH), 128.0 (CH), 
122.9 (CH2), 80.7 (C), 77.4 (CH), 64.2 (CH), 28.4 (CH3), 28.4 (CH3), 28.4 (CH3), 27.0 (CH3). 
HPLC-MS (ESI): m/z 303.36 (MH+). 
 
Preparation of (S)-2-(9-Fluorenylmethylcarbonylamino)-3-methyl-N-methyl-N-propargyl- 
butanamide (10) 
DCC (10 mmol), 2a (8.3 mmol) and DMAP (0.125 mmol) in anhydrous CH2 l2 (60 mL), cooled at 
0 °C, were slowly added to a solution of 9 (10 mmol). The resulting solution was stirred at r.t. for 
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48h, then filtered on a path of silica gel. The solvent was evaporated under reduced pressure and the 
crude residue was purified by flash chromatography (Cyclohexane / AcOEt 7:3).  
Yield: 90%. White foam. Rotamers ratio 4:1; 1H NMR (599 MHz, CDCl3, T = 25°C) δ: 0.95 (3H, d, 
J = 6.6 Hz), 1.01 (3H, d, J = 6.6 Hz), 2.03 (1H, dq, J = 13.1, 6.6 Hz), 2.24 (1H, t, J = 2.3 Hz), 3.19 
(3H, s), 4.10 (1H, dd, J = 17.3, 2.1 Hz), 4.23 (1H, t, J = 6.9 Hz), 4.34 (1H, dd, J = 10.5, 7.2 Hz), 
4.41 (2H, m), 4.56 (1H, dd, J = 9.2, 5.9 Hz), 5.61 (1H, d, J = 9.2 Hz), 7.32 (2H, t, J = 7.4 Hz), 7.41 
(2H, td, J = 7.4, 2.6 Hz), 7.61 (2H, dd, J = 6.9, 4.3 Hz), 7.77 (2H, d, J = 7.6 Hz)  (major rotamer); 
0.95 (3H, d, J = 6.6 Hz), 1.01 (3H, d, J = 6.6 Hz), 2.09 (1H, dq), 2.33 (1H, t), 3.04 (3H, s), 4.01 
(1H, dd), 4.23 (1H, t, J = 6.9 Hz), 4.34 (1H, dd, J = 10.5, 7.2 Hz), 4.41 (2H, m), 4.51 (1H, dd), 5.57 
(1H, d), 7.32 (2H, t, J = 7.4 Hz), 7.41 (2H, td, J = 7.4, 2.6 Hz), 7.61 (2H, dd, J = 6.9, 4.3 Hz), 7.77 
(2H, d, J = 7.6 Hz), (minor rotamer); 13C NMR (150.81 MHz, CDCl3, T = 25°C) δ: 17.3 (q), 19.4 
(q), 31.6 (d), 34.6 (q), 36.6 (t), 47.1 (d), 55.5 (d), 67.0 (t), 72.1 (d), 78.1 (s), 119.9 (d), 119.9 (d) 
125.1 (d), 125.1 (d), 127.0 (d), 127.0 (d), 127.6 (d), 127.6 (d), 141.2 (s), 141.2 (s), 143.7 (s), 143.8 
(s), 156.4 (s), 171.7 (s), (major rotamer); 17.4 (q), 19.6 (q), 31.5 (d), 33.3 (q), 39.3 (t), 47.1 (d), 55.7 
(d), 67.0 (t), 73.2 (d), 77.6 (s), 119.9 (d), 119.9 (d) 125.1 (d), 125.1 (d), 127.0 (d), 127.0 (d), 127.6 
(d), 127.6 (d), 141.2 (s), 141.2 (s), 143.7 (s), 143.8 (s), 156.3 (s), 171.7 (s), (minor rotamer); HPLC-
MS (ESI): m/z 391.47 (MH+) 
Synthesis of (2S)-2-amino-N,3-dimethyl-N-(prop-2-yn-1-yl)butanamide (11) 
Piperidine (4.12 mmol) was added to a solution of 10 (20 mmol) in dry acetonitrile (500ml).The 
resulting mixture was left under stirring for 6 h ten the solvent was evaporated to dryness. The 
crude residue was purified by flash chromatography (EtOAc / MeOH / TEA 9:0.5:0.5). 
Yield: 78%. Red oil. 1H NMR (400 MHz, CDCl3, T = 25°C) δ: 0.34 (3H, d, J = 6.8 Hz), 1.01 (3H, 
d, J = 6.8 Hz), 1.91 (1H, m), 2.23 (1H, dd, J = 2.5, 2.5 Hz), 3.14 (3H, s), 3.51 (1H, d, J = 5.4 Hz), 
4.19 (1H, dd, J = 17.3, 2.5 Hz), 4.13 (2H, br.s.), 4.35 (1H, dd, J = 17.3, 2.5 Hz), (major rotamer); 
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0.92-1.03 (6H, m), 1.91 (1H, m), 2.34 (1H, dd, J = 2.1, 2.1 Hz), 3.05 (3H, s), 3.49 (1H, d), 4.13 
(2H, br.s.), 4.16-4.39 (2H, m), (minor rotamer). HPLC-MS (ESI): m/z 303.36 (MH+) 169.39 
Synthesis of (2S)-2-(benzylamino)-N,3-dimethyl-N-(prop-2-yn-1-yl)butanamide (12) 
To a solution of 11 (5.1 mmol) and pyridine (0.45 ml) in dry dichloromethane was slowly added 
benzylbromide (5.6 mmol) dissolved in dry dichloromethane (4 ml) at 0°C. The resulting mixture 
was left under stirring overnight at room temperature. The solution was diluted with 
dichloromethane (30 ml) and washed with water (10 ml). The organic phase was dried over sodium 
sulphate, filtered, and the solvent evaporated under reduced pressure.The resulting crude was 
purified by flash chromatography (Cyclohexane / EtOAc 7:3). 
Yield: 50%. White solid. Rotamers ratio 2.5:1.1H NMR (400 MHz, CDCl3, T = 25°C) δ: 0.95 (3H, 
d, J = 6.8 Hz), 1.00 (3H, d, J = 6.6 Hz), 1.79-1.90 (1H, m), 2.25 (1H, dd, J = 2.3, 2.3 Hz), 2.96 (3H, 
s), 3.22 (1H, d, J = 6.4 Hz), 3.51 (1H, d, J = 13.2 Hz), 3.85 (1H, d, J = 13.2), 4.22 (1H, dd, J = 
17.1, 2.5 Hz), 4.35 (1H, d, J = 17.1, 2.5 Hz), 7.23-7.40 (5H,m), (major rotamer); 0.98-0.99 (6H, m), 
1.79-1.90 (1H, m), 2.30 (1H, dd, J = 2.3, 2.3 Hz), 3.06 (3H, s), 3.27 (1H, d, J = 5.8 Hz), 3.51 (1H, 
d, J = 13.0 Hz), 3.83 (1H, d, J = 13.0 Hz), 3.95 (1H, dd, J = 18.1, 2.3 Hz), 4.10 (1H, dd, J = 18.1, 
2.3 Hz), 7.23-7.40 (5H,m), (minor rotamer);13C NMR (100 MHz, CDCl3, T = 25°C) δ: 18.3 (q), 
19.7 (q), 31.7 (d), 34.2 (q), 36.5(t), 61.9 (d), 71.8 (s), 78.7 (s), 126.9 (d), 128.2 (d), 128.2 (d), 128.3 
(d), 128.3 (d), 140.3 (s), 175.1 (s),(major rotamer); 18.0 (q), 20.1 (q), 31.6 (d), 33.3 (q), 38.8 (t),
52.3 (d), 72.9 (d), 78.1 (s), 126.8 (d), 128.2 (d),128.2 (d), 128.3 (d), 128.3 (d), 140.4 (s), 174.9 (s), 






Synthesis of (2S)-2-(benzylamino)-N,3-dimethyl-N-propadienylbutanamide (13) 
t-BuOK (2.5 mmol) in THF (10 mL) was added to a soluti n of 12 (1 mmol). The resulting solution 
was stirred at r.t. for 1 min, then filtered on silica gel (AcOEt). The solvent was evaporated under 
reduced pressure and the residue was purified by flash chromatography (Cyclohexane / EtOAc 8:2). 
Yield: 50%. Light yellow oil. Rotamers ratio 1:1. 1H NMR (599.7 MHz, MeOD, T = 25°C) δ: 0.91-
0.99 (6H, m), 1.80-190 (1H, m), 2.94 (1H, s), 3.51-3.55 (1H,m), 3.53-3.54 (1H, m), 3.68-3.75 (1H, 
m), 5.44-5.47 (2H, m), 7.21-7.25 (1H, m), 7.28-7.33 (4H, m), 7.49 (1H, m),(first rotamer); 0.91-
0.99 (6H, m), 1.80-1.90 (1H, m), 2.99 (1H, s), 3.43-3.45 (1H, m), 3.51-3.55 (1H, m), 3.68-3.75 (1H, 
m), 5.38-5.44 (2H, m), 6.98 (1H, m), 7.21-7.25 (1H, m), 7.28-7.33 (4H,m), (second rotamer);13C 
NMR (150.81 MHz, MeOD, T = 25°C) δ: 18.4 (q), 20.04 (q), 32.1 (q), 33.0 (q), 53.3 (t), 63.8 (d), 
87.0 (t), 100.20 (d), 128.2 (d), 129.4 (d), 129.4 (d), 129.6 (d), 129.6 (d), 141.1 (s), 175.15 (s), 202.8 
(s), (first rotamer); 18.6 (q), 20.0 (q), 33.0 (d), 33.5 (q), 53.5 (t), 63.8 (t) 87.7 (t), 101.7 (d), 128.3 
(d), 129.5 (d), 129.5 (d), 129.6 (d), 129.6 (d), 141.  (s), 175.6 (s), 203.9 (s), (second rotamer). 
HPLC-MS (ESI): m/z 259.53 (MH+) 
Procedures for cyclization of allenamide (13) 
a) To a stirred solution of 13 ( 2.42 mmol)  in dry acetonitrile (40 ml) was added AuCl3 (0.121 
mmol), under argon atmosphere. The mixture so obtained was refluxed for 20 minutes, then the 
solvent was removed under reduced pressure. The crude residue was purified by flash column 
chromatography (Cyclohexane / EtOAc 7.5:2.5). 
b) To a mixture of PPh3AuCl (0.12 mmol) and AgBF4(0.12 mmol) in dry acetonitrile (30 ml) was 
added, under argon atmosphere, a solution of 13 (2.59 mmol) in dry acetonitrile (10 ml). The 
mixture so obtained was refluxed for 2.5h, then the solvent was removed under reduced pressure. 





Colourless oil. Yield: (using procedure a) 24%, (using procedure b) 14%. 1H NMR (599.7 MHz, 
CDCl3, T = 25°C) δ: 1.00 (3H, d, J = 6.9 Hz), 1.11 (3H, d, J = 7.1 Hz), 2.08 (1H, m, J = 14.0, 7.0, 
2.8 Hz), 2.70 (3H, s), 3.33 (1H, t, J = 2.6 Hz), 3.79 (1H, d, J = 14.3 Hz), 3.92 (1H, d, J = 14.5 Hz), 
4.51 (1H, dd, J = 9.0, 2.1 Hz), 5.10 (1H, d, J = 17.0 Hz), 5.35 (1H, d, J = 10.0 Hz), 5.61 (1H, dt, J = 
16.9, 9.5 Hz), 7.22 (1H, m), 7.30 (4H, m);13C NMR (150.81 MHz, CDCl3, T = 25°C) δ: 17.3 (q), 
18.1 (q), 26.4 (q), 29.0 (d), 50.74 (t), 66.1 (d), 79.4 (d), 122.0 (t), 126.9 (d), 128.0 (d), 128.0 (d),
128.1 (d), 128.1 (d), 134.1 (d), 138.3 (s), 171.8 (s). HPLC-MS (ESI): m/z 259.53 (MH+) 
(2S,5S)-1-benzyl-2-ethenyl-3-methyl-5-(propan-2-yl)imidazolidin-4-one (cis-14b) 
Light yellow oil. Yield: (using procedure a) 36%, (using procedure b) 21%.1H NMR (599.7 MHz, 
CDCl3, T = 25°C) δ: 0.96 (3H, d, J = 6.9 Hz), 1.00 (3H, d, J = 7.1 Hz), 1.88 (1H, m, J = 13.9, 7.0, 
3.0 Hz), 2.65 (3H, s), 3.26 (1H, d, J = 2.3 Hz), 3.83 (2H, m), 4.22 (1H, d, J = 8.4 Hz), 5.05 (1H, d, J
= 17.3 Hz), 5.10 (1H, d, J = 9.9 Hz), 5.47 (1H, ddd, J = 17.2, 9.9, 8.5 Hz), 7.23 (5H, m);13C NMR 
(150.81 MHz, CDCl3, T = 25°C) δ: 17.6 (q), 17.7 (q), 26.3 (q), 29.9 (d), 57.5 (t), 68.8 (d), 82.1 (d), 
119.7 (t), 127.1 (d), 127.9 (d), 127.9 (d), 128.9 (d), 128.9 (d), 137.3 (d), 137.6 (s), 171.6 (s). HPLC-
MS (ESI): m/z 259.53 (MH+) 
1H-pyrrole-2-carboxylic acid (15a) 
The compound is commercial available by Aldrich. 
1-methyl-1H-pyrrole-2-carboxylic acid (15b) 
The compound is commercial available by Aldrich. 
N-methylprop-2-yn-1-amine (2a) 
The compound is commercial available by Aldrich. 
Prop-2-yn-1-amine (2b) 




The compound is known in literature82. 
4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide (2d) 
The compound is known in literature83. 
N-methyl-3-phenylprop-2-yn-1-amine (2e) 
The compound is known in literature84. 
4-methyl-N-(3-phenylprop-2-yn-1-yl)benzenesulfonamide (2f) 
The compound is known in literature85. 
N-benzyl-3-phenylprop-2-yn-1-amine (2g) 
The compound is known in literature86. 
Synthesis of N-methyl-N-(prop-2-yn-1-yl)-1H-pyrrole-2-carboxamide (16a) 
A 100 ml round bottom flask fitted with a magnetic stirrer and a thermometer was charged with 1.5 
g (13,5 mmol) of 1H-pyrrole-2-carboxylic acid (15a) and 30 ml of dry dichloromethane under 
argon atmosphere.The solution so obtained was stirred at rt for 10 minutes then cooled down to 
0°C. To this, a solution of DCC 2.78 g (23.9 mmol) in 8 ml of dry dichloromethane, was slowly 
dropped in 20 minutes keeping the internal temperature between 0-5°C. To this mixture N-
methylprop-2-yn-1-amine (2a) 0.94 ml (11.1 mmol) was added followed by DMAP 0.020 g (0.16 
mmol). The mixture was left at rt under stirring for 48h, then diluted with 100ml of EtOAc, filtered 
through a small celite pad washed and rinsed with EtOAc, and the filtrate concentrated under 
reduced pressure The crude residue was then purified by flash column chromatography 
(Cycloehexane / EtOAc, 6:4). 
Yield: 80%. White solid. 1H NMR (599.71 MHz, CDCl3, T= 50°C) δ: 9.85 (1H, br.s.), 6.94 (m, 
1H), 6.71 (br.s., 1H), 6.27 (m, 1H), 4.40 (d, 2H, J = 2.5 Hz), 3.31 (br.s., 3H), 2.30 (t, 1H J = 2.6 
Hz);13C NMR (150.81 MHz, CDCl3, T= 50°C) δ 162.36 (C),  124.55 (C), 121.40 (CH), 112.86 
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(CH), 109.81 (CH), 78.86 (C), 72.28 (CH), 38.83 (CH2), 35.28 (CH3); HPLC-MS (ESI): m/z = 
163.18 [MH+]. 
Synthesis of N,1-dimethyl-N-(prop-2-yn-1-yl)-1H-pyrrole-2-carboxamide (16b) 
A 100 ml round bottom flask  fitted with a magnetic stirrer and a thermometer was charged with 3 g 
(23,9 mmol) of 1-methyl-1H-pyrrole-2-carboxylic acid (15b) and 45 ml of dry dichloromethane 
under argon atmosphere.The solution so obtained was stirred at rt for 10 minutes then cooled down 
to 0°C. To this, a solution of DCC 4.93 g (23.9 mmol) in 15ml of dry dichloromethane, was slowly 
dropped in 20 minutes keeping the internal temperature between 0-5°C. To this mixture N-
methylprop-2-yn-1-amine (2a) 1.67 ml (19.8 mmol) was added followed by DMAP 0.036 g (0.29 
mmol). The mixture was left at rt under stirring for 48h, then diluted with 200ml of EtOAc, filtered 
through a small celite pad washed and rinsed with EtOAc, and the filtrate was concentrated under 
reduced pressure The crude residue was then purified by flash column chromatography 
(Cycloehexane / EtOAc, 6:4). 
Yield: 91.6%. Colorless oil. IR = 1672 cm-1. 1H NMR (599.71 MHz, CDCl3, T= 50°C) δ 6.69 (t, 
1H, J = 2.0 Hz), 6.54 (dd, 1H, J = 3.7, 1.1 Hz), 6.09. (dd, 1H, J = 3.9, 2.7 Hz), 4.32 (d, 2H, J = 2.6 
Hz), 3.79 (s, 3H), 3.19 (s, 3H), 2.30 (t, 1H J = 2.5 Hz);13C NMR (150.81 MHz, CDCl3, T= 50°C) δ 
163.79 (C), 126.68 (CH), 124.70 (C), 113.45 (CH), 106.95 (CH), 79.04 (C), 72.26 (CH), 39.28 
(CH2), 35.76 (CH3), 34.84 (CH3); HPLC-MS (ESI): m/z = 177.21 [MH+].Anal.calcd for C10H12N2O: 
C, 68.16; H, 6.86; N, 15.90. Found C, 68.32; H, 6.89; N, 15.85. 
General procedure for the cyclization of pyrrole-carboxamides: A solution of 2 mmol of the 
appropriate pyrrole-carboxamide was stirred, under argon atmosphere, with AuCl3 (0.01 mmol) in 
30 mL of an appropriate solvent (see Tables 7-8 and 9 for solvents, temperatures and times). At the 
end of the reaction, the solvent was either removed under reduced pressure (MeCN, DCM, Toluene) 




1,4,6-trimethyl-1,6-dihydro-7H-pyrrolo[2,3-c]pyridin-7-one (17b)  
Yield: 70% (Table 2, entry 1). White solid. M. p.: 76 °C. IR = 1670 cm-1. 
1H-NMR (599 MHz, 
CDCl3, T= 25 °C) δ: 2.13 (s, 3H), 3.49 (s, 3H), 4.13 (s, 3H), 6.17 (d, J = 2.9 Hz, 1H), 6.57 (s, 1H), 
6.91 (d, J = 2.9 Hz, 1H); 13C-NMR (150 MHz, CDCl3, T = 25 °C) δ: 14.75 (q), 35.56 (q), 35.57 (q), 
100.06 (d), 110.30 (s), 122.33 (s), 126.21 (d), 130.78 (d), 132.48 (s), 155.64 (s). HPLC-MS (ESI): 
m/z = 177.21 [MH+]. Anal. calcd for C10H12N2O: C, 68.16; H, 6.86; N, 15.90. Found C, 68.22; H, 
6.80; N, 15.95.  
 
1,5,7-trimethyl-1,5-dihydro-4H-pyrrolo[3,2-c]pyridin-4-one (18b) 
Yield: 50% (Table 2, entry 4). Yellow solid. M. p.: 104 °C. IR = 1672 cm-1. 
1H-NMR (599 MHz, 
CDCl3, T = 25 °C) δ: 2.37 (s, 3H), 3.51 (s, 3H), 3.89 (s, 3H), 6.65 (s, 1H), 6.69 (d, J = 3.1 Hz, 1H), 
6.73 (d, J = 3.1 Hz, 1H); 13C-NMR (150 MHz, CDCl3, T= 25 °C) δ 16.11 (q), 35.84 (q), 35.86 (q), 
104.39 (d), 104.55 (s), 116.90 (s), 127.39 (d), 129.78 (d), 137.93 (s), 159.63 (s); HPLC-MS (ESI): 
m/z = 177.21 [MH+]. Anal. calcd for C10H12N2O: C, 68.16; H, 6.86; N, 15.90. Found C, 68.13; H, 
6.81; N, 15.94. 
 
Synthesis of 1-methyl-N-(prop-2-yn-1-yl)-1H-pyrrole-2-carboxamide. (19) 
A 50 ml round bottom flask fitted with a magnetic stirrer and a thermometer was charged with 1 g 
(7.9 mmol) of 1-methyl-1H-pyrrole-2-carboxylic acid (15b) and 15 ml of dry dichloromethane 
under argon atmosphere.The solution so obtained was stirred at rt for 10 minutes then cooled down 
to 0°C. To this, a solution of DCC 1.64 g (7.9 mmol) in 5 ml of dry dichloromethane, was slowly 
dropped in 20 minutes keeping the internal temperature between 0-5°C. To this mixture prop-2-yn-
1-amine (2b) 0.42 ml (6.6 mmol) was added followed by DMAP 0.012 g (0.098 mmol). The 
mixture was left at rt under stirring for 48h, then diluted with 100ml of EtOAc, filtered through a 
small celite pad washed and rinsed with EtOAc, and the filtrate concentrated under reduced 
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pressure. The crude residue was then purified by flash column chromatography (Cycloehexane / 
EtOAc, 6:4) 
Yield: 80%. White solid.1H NMR (599.71 MHz, CDCl3, T= 25°C) δ 6.73 (t, 1H, J = 2.2 Hz), 6.59 
(dd, 1H, J = 3.9, 1.6 Hz), 6.09 (dd, 1H, J = 3.7, 2.7 Hz), 6.07 (br.s., 1H), 4.17 (dd, 2H, J = 5.4, 2.6 
Hz), 3.94 (s, 3H), 2.25 (t, 1H J = 2.5 Hz);13C NMR (150.81 MHz, CDCl3, T= 50°C) δ 161.39 (C),  
128.25 (CH), 124.91 (C), 112.41 (CH), 107.28 (CH), 79.87 (C), 71.37 (CH), 36.72 (CH3), 28.87 
(CH2); HPLC-MS (ESI): m/z = 163.18 [MH+]. 
 
Synthesis of N-benzyl-1-methyl-N-(prop-2-yn-1-yl)-1H-pyrrole-2-carboxamide (20a) 
A 50 ml round bottom flask fitted with a magnetic stirrer and a thermometer was charged with 1 g 
(8 mmol) of 1-methyl-1H-pyrrole-2-carboxylic acid (15b) and 15 ml of dry dichloromethane under 
argon atmosphere.The solution so obtained was stirred at rt for 10 minutes then cooled down to 
0°C. To this, a solution of DCC 1.64 g (8 mmol) in 5ml of dry dichloromethane, was slowly 
dropped in 20 minutes keeping the internal temperature between 0-5°C. To this mixture N-
benzyllprop-2-yn-1-amine (2c) 0.95 g (6.6 mmol) was added followed by DMAP 0.012 g (0.098 
mmol). The mixture was left at rt under stirring for 48h, then diluted with 70ml of EtOAc, filtered 
through a small celite pad washed and rinsed with EtOAc, and the filtrate concentrated under 
reduced pressure The crude residue was then purified by flash column chromatography 
(Cycloehexane/Cyclopentilmethylether, 6:4) 
Yield: 85%.Colourless oil. IR = 1666 cm-1. 1H NMR (599.71 MHz, CDCl3, T= 25°C) δ  7.37 (m, 
2H), 7.33 (m, 2H), 7.30 (m, 1H), 6.73 (m, 1H), 6.60 (br.s., 1H), 6.08 (m, 1H), 4.90 (s, 2H), 4.25 
(br.s., 2H), 3.85 (s, 3H), 2.31 (br.s., 1H);13C NMR (150.81 MHz, CDCl3, T= 25°C) δ 164.08 (C),  
136.85 (C), 128.74 (CH), 128.74 (CH), 127.78 (CH), 127.78 (CH), 127.55 (CH), 127.00 (CH), 
124.69 (C), 113.09 (CH), 107.12 (CH), 79.24 (C), 72.34 (CH), 49.88 (CH2), 36.67 (CH2), 35.92 
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(CH3); HPLC-MS (ESI): m/z = 253.31 [MH+]. Anal.calcd for C16H16N2O: C, 76.16; H, 6.39; N, 
11.10. Found C, 76.21; H, 6.28; N, 11.12. 
Synthesis of 1-methyl-N-[(4-methylphenyl)sulfonyl]-N-(prop-2-yn-1-yl)-1H-pyrrole-2-
carboxamide (20b) 
To a stirred solution of 1.2 g (9.59 mmol) of 1-methyl-1H-pyrrole-2-carboxylic acid (15b) in 21ml 
of dry THF containing 2 drops of N,N-dimethylformamide was added 1.25 ml (14.3 mmol) of 
oxalylchloride. The resulting mixture was stirred at rt for 3h after wich time the solvent was 
removed under reduced pressure and then taken up in 15 ml of dry THF. 
In a separate flask, to a suspension of 0.137 g of NaH (5.74 mmol) in 10 ml of dry THF cooled to 
0°C was added 1g (4.79 mmol) of 4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide (2d), dissolved 
in 10 ml of dry THF, dropping in 15 minutes. The mixture was allowed to stir at 0°C for 30 
minutes, after which time, the preformed acid chloride was added via siringe and the resulting 
mixture was allowed to warm to rt overnight. The mixture was quenched at 0°C with 20 ml of water 
and exctracted with 80 ml of AcOEt. Phase were allowed to separated, the aqueous phase was 
discharged and the organic phase was washed two times with 20 ml of water, dried over Na2SO4 
and the solvent removed under reduced pressure. The crude residue was subjected to silica gel 
chromatography (EtOAc / Cyclohexane, 3:7)  
Yield: 77%. White solid. M.p.: 127 0C. IR = 1674 cm-1. 1H NMR (599.71 MHz, CDCl3, T= 25°C) δ  
7.91 (m, 2H), 7.31 (m, 2H), 7.06 (dd, 1H, J = 4.1, 1.6 Hz), 6.80 (t, 1H, J = 2.1 Hz), 6.13 (dd, 1H, J 
= 4.3, 2.5 Hz), 4.67 (d, 2H, J = 2.5 Hz), 3.69 (s, 3H), 2.43 (s, 3H), 2.38  (t, 1H, J = 2.5 Hz); 13C 
NMR (150.81 MHz, CDCl3, T= 25°C) δ 162.15 (C),  144.57 (C), 135.77 (C), 130.73 (CH), 129.31 
(CH), 129.31 (CH), 128.67 (CH), 128.67 (CH), 124.16 (C), 118.98 (CH), 108.16 (CH), 78.88 (C), 
73.09 (CH), 30.07 (CH2), 36.21 (CH3), 21.62 (CH3); HPLC-MS (ESI): m/z =317.37 [MH+]. Anal. 




Synthesis of tert-butyl [(1-methyl-1H-pyrrol-2-yl)carbonyl]prop-2-yn-1-ylcarbamate (20c) 
To a stirred solution of 0.81 g (5 mmol) of 1-methyl-N-(prop-2-yn-1-yl)-1H-pyrrole-2-carboxamide. 
(19), in 60 ml of acetonitrile was added 1.26 g (5.8 mmol) of di-tert-butyl dicarbonate, followed by 
0.061 g ( 0.5 mmol) of 4-dimethylaminopyridine. The resulting solution was allowed to stir at rt 
overnight and the solvent was removed under reduced pr ssure. The crude residue was subject to 
flash column chromatography (Cycloehexane / EtOAc, 8:2)
Yield: 85%. Colourless oil. IR = 1726, 1667 cm-1. 1H NMR (599.71 MHz, CDCl3, T= 25°C) δ  6.80 
(t, 1H, J = 2.2 Hz), 6.62 (m, 1H), 6.11 (m, 1H), 4.43 (d, 2H, J = 2.5 Hz ), 3.86 (s, 3H), 2.23 (t, 1H, J 
= 2.4 Hz), 1.36 (s, 8H);13C NMR (150.81 MHz, CDCl3, T= 25°C) δ 160.24 (C),  153.14 (C), 129.39 
(CH), 127.57 (C), 117.83 (CH), 107.88 (CH), 82.78 (C), 79.32 (C), 70.90 (CH), 36.02 (CH2), 35.03 
(CH3), 27.73 (CH3), 27.73 (CH3)  27.73 (CH3); HPLC-MS (ESI): m/z = 263.30 [MH+]. Anal. calcd 
for C14H18N2O3: C, 64.10; H, 6.92; N, 10.68. Found C, 64.15; H, 7.04; N, 10.54. 
 
Synthesis of 1-methyl-N-(phenylcarbonyl)-N-(prop-2-yn-1-yl)-1H-pyrrole-2-carboxamide (20-
d) 
To a stirred suspension of 0.137 g (5.72 mmol) of NaH in 20 ml of dry THF was slowly added a 
solution of 0.77 g ( 4.7 mmol) of 1-methyl-N-(phenylcarbonyl)-N-(prop-2-yn-1-yl)-1H-pyrrole-2-
carboxamide (19) in 20 ml of dry THF at 0°C followed by 7ml of dry DMF. The mixture was left 
under stirring at 0°C for 0.5 h then 0.66 ml (5.7 mmol) of benzoylchloride were added. The mixture 
was allowed to stir for 3h at rt after wich time 10 ml of water were added followed by 30 ml of tert-
butylmethylether. Phases were allowed to separated, the aqueous phase was discharge and the 
organic one was washed two times with 10ml of water th n dried over sodium sulphate and the 
solvent evaporated under reduced pressure. The crud residue was then purified by flash column 
chromatography (Cycloehexane / Cyclopentylmethylether, 6.5:3.5) 
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Yield: 60%. Colourless oil.1H NMR (599.71 MHz, CDCl3, T= 25°C) δ  7.51 (d, 2H, J = 7.9 Hz), 
7.32 (m, 1H), 7.26 (m, 2H), 6.62 (dd, 1H, J = 3.9, 1.2 Hz), 6.60 (t, 1H, J = 2.2 Hz), 5.92 (dd, 1H, J 
= 3.7, 2.7 Hz), 4.72 (d, 2H, J = 2.5 Hz), 3.71 (s, 3H), 2.28 (t, 1H, J = 2.4 Hz);13C NMR (150.81 
MHz, CDCl3, T= 25°C) δ 172.32 (C), 164.93 (C), 136.81 (C), 131.37 (CH), 130.75 (CH), 128.15 
(CH), 128.15 (CH), 127.91 (CH), 127.91 (CH), 127.91 (C), 119.66 (CH), 108.50 (CH), 78.72 (C),  
72.54 (CH), 35.89 (CH2), 35.86 (CH3); HPLC-MS (ESI): m/z = 267.29 [MH+].  
Synthesis of N,1-dimethyl-N-(3-phenylprop-2-yn-1-yl)-1H-pyrrole-2-carboxamide (20e) 
A 25 ml round bottom flask fitted with a magnetic stirrer and a thermometer was charged with 0.62 
g (4.9 mmol) of 1-methyl-1H-pyrrole-2-carboxylic acid (15b) and 8 ml of dry dichloromethane 
under argon atmosphere.The solution so obtained was stirred at rt for 10minutes then cooled down 
to 0°C. To this, a solution of DCC 1.02 g (4.9 mmol) in 4ml of dry dichloromethane, was slowly 
dropped in 20 minutes keeping the internal temperature between 0-5°C. To this mixture N-methyl-
3-phenylprop-2-yn-1-amine (2e) 0.6 g (19.8 mmol) was added followed by DMAP 0.008 g (0.06 
mmol). The mixture was left at rt under stirring for 48h, then diluted with 50ml of EtOAc, filtered 
through a small celite pad washed and rinsed with EtOAc, and the filtrate concentrated under 
reduced pressure The crude residue was then purified by flash column chromatography 
(Cyclopentylmethylether / EtOAc, 1:1) 
Yield: 90%.Colourless oil. IR = 1668 cm-1 1H NMR (599.71 MHz, CDCl3, T= 50°C) δ  7.46 (m, 
2H), 7.32 (m, 3H), 6.72 (s, 1H), 6.61 (m, 1H), 6.12 (t, 1H), 4.57 (s, 2H), 3.82 (s, 3H), 3.26 (s, 
3H);13C NMR (150.81 MHz, CDCl3, T= 50°C) δ 164.02 (C), 131.96 (CH), 131.96 (CH), 128.59 
(CH), 128.48 (CH), 128.48 (CH), 126.82 (CH), 125.11 (C), 122.95 (C), 113.65 (CH), 107.17 (CH), 
84.58 (C), 84.55 (C), 40.51 (CH2), 36.01 (CH3),  34.98 (CH3); HPLC-MS (ESI): m/z = 253.31 







To a stirred solution of 0.43 g (3.5 mmol) of 1-methyl-1H-pyrrole-2-carboxylic acid (15b) in 8 ml 
of dry THF containing 2 drops of N,N-dimethylformamide was added 0.45 ml (5.25 mmol) of 
oxalylchloride. The resulting mixture was stirred at rt for 3h after wich time the solvent was 
removed under reduced pressure and then taken up in 8 ml of dry THF. 
In a separate flask, to a suspension of 0.049 g of NaH (2.0 mmol) in 7 ml of dry THF cooled to 0°C 
was added 0.5 g (1.74 mmol) of 4-methyl-N-(3-phenylprop-2-yn-1-yl)benzenesulfonamide (2f), 
dissolved in 6 ml of dry THF, dropping in 15 minutes. The mixture was allowed to stir at 0°C for 30 
minutes, after which time, the preformed acid chloride was added via siringe and the resulting 
mixture was allowed to warm to rt overnight. The mixture was quenched at 0°C with 10 ml of water 
and exctracted with 40 ml of AcOEt. Phase were allowed to separated, the aqueous phase was 
discharged and the organic phase was washed two times with 10 ml of water, dried over Na2SO4 
and the solvent removed under reduced pressure. The crude residue was subjected to silica gel 
chromatography (Cyclohexane / EtOAc, 7:3)  
Yield: 90%. White solid. M.p.: 110 0C. IR = 1668 cm-1. 1H NMR (599.71 MHz, CDCl3, T= 25°C) δ  
8.01 (d, 2H, J= 8.4 Hz), 7.31 (m, 7H), 7.09 (dd, 1H, J = 4.0, 1.6 Hz), 6.82 (t, 1H, J = 2.1 Hz), 6.15 
(dd, 1H, J = 4.0, 2.6 Hz), 4.93 (s, 2H), 3.73 (s, 3H), 2.40 (s, 3H);13C NMR (150.81 MHz, CDCl3, 
T= 25°C) δ 162.39 (C), 144.43 (C), 136.08 (C), 131.65 (CH), 131.65 (CH), 130.61 (CH), 129.25 
(CH), 129.25 (CH), 128.85 (CH), 128.85 (CH), 128.60 (CH), 128.24 (CH), 128.24 (CH), 124.27 
(C), 122.18 (C), 118.67 (CH), 108.18 (CH), 85.05 (C), 84.14 (C), 39.39 (CH2), 36.27 (CH3), 21.58 
(CH3); HPLC-MS (ESI): m/z = 393.47 [MH+]. Anal. calcd for C22H20N2O3S: C, 67.33; H, 5.14; N, 





Synthesis of N-benzyl-1-methyl-N-(3-phenylprop-2-yn-1-yl)-1H-pyrrole-2-carboxamide (20g) 
A 25 ml round bottom flask fitted with a magnetic stirrer and a thermometer was charged with 0.63 
g (5 mmol) of 1-methyl-1H-pyrrole-2-carboxylic acid (15b) and 8 ml of dry dichloromethane under 
argon atmosphere.The solution so obtained was stirred at rt for 10minutes then cooled down to 0°C. 
To this, a solution of DCC 1.04 g (5 mmol) in 4ml of dry dichloromethane, was slowly dropped in 
20 minutes keeping the internal temperature between 0-5°C. To this mixture N-benzyl-3-
phenylprop-2-yn-1-amine (2g) 0.93 g (4.2 mmol) was added followed by DMAP 0.008 g (0.06 
mmol). The mixture was left at rt under stirring for 48h, then diluted with 50ml of EtOAc, filtered 
through a small celite pad washed and rinsed with EtOAc, and the filtrate concentrated under 
reduced pressure The crude residue was then purified by flash column chromatography (Toluen / 
EtOAc, 9:1)  
Yield: 80%. Yellow oil. IR = 1667 cm-1.1H NMR (599.71 MHz, CDCl3, T= 50°C) δ  7.44 (m, 2H), 
7.38 (m, 4H), 7.32 (m, 4H), 6.74 (t, 1H, J = 1.7 Hz), 6.67 (br.s., 1H), 6.10 (t, 1H, J = 3.2 Hz), 4.96 
(s, 2H), 4.49 (s ,3H), 3.86 (s, 3H);13C NMR (150.81 MHz, CDCl3, T= 50°C) δ 164.07 (C), 137.12 
(C), 131.80 (CH), 131.80 (CH), 128.72 (CH), 128.72 (CH), 128.40 (CH), 128.30 (CH), 128.30 
(CH), 127.89 (CH), 127.89 (CH), 127.50 (CH), 126.92 (CH), 124.90 (C), 122.79 (C), 113.12 (CH), 
107.14 (CH), 84.61 (C), 84.51 (C), 49.98 (CH2), 37.92 (CH2), 35.94 (CH3); HPLC-MS (ESI): m/z = 




Yields: 85% (in TBME), 75% (in dichloromethane), 65% (in Toluene), 70% (in acetonitrile), 60% 
(in DMF). White solid. M.p.: 2010C. IR = 1673cm-1. 1H NMR (599.71 MHz, CDCl3, T= 25°C) δ 
7.98 (m, 2H), 7.55 (q, 1H, J = 1.4 Hz), 7.33 (m, 2H), 6.98 (d, 1H, J = 2.8 Hz), 6.21 (d, 1H, J = 2.6 
Hz), 4.01 (s, 3H), 2.43 (s, 3H), 2.23 (d, 3H, J = 1.5 Hz); 13C NMR (150.81 MHz, CDCl3, T= 25°C) 
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δ 153.95 (C),  144.96 (C), 135.34 (C), 133.72 (C), 132.82 (CH), 129.35 (CH), 129.35 (CH), 128.99 
(CH), 128.99 (CH), 121.45 (C), 119.77 (CH), 111.83 (C), 101.42 (CH), 36.15 (CH3), 21.68 (CH3), 
15.30 (CH3); HPLC-MS (ESI): m/z = 317.37 [MH+]. Anal. calcd for C16H16N2OS3: C,60.74; H, 
5.10; N, 8.85. Found C, 60.78; H, 5.11; N, 8.77  
1,7-dimethyl-5-[(4-methylphenyl)sulfonyl]-1,5-dihydro-4H-pyrrolo[3,2-c]pyridin-4-one (22b) 
Yield: 7.5% (in TBME), 9% (in dichloromethane), 14% (in toluene), 20% (in acetonitrile), 25% (in 
DMF). Yellow solid. M.p.: 2150C. IR = 1673 cm-1.1H NMR (599.71 MHz, CDCl3, T= 25°C) δ 7.98 
(m, 2H), 7.59 (q, 1H, J = 1.3 Hz), 7.30 (m, 2H), 6.66 (m, 2H), 3.90 (s, 3H), 2.44 (d, 3H, J = 1.3 Hz), 
2.40 (s, 3H); 13C NMR (150.81 MHz, CDCl3, T= 25°C) δ 157.42 (C),  145.19 (C), 138.13 (C), 
134.94 (C), 129.28 (CH), 129.28 (CH), 129.28 (CH), 129.28 (CH), 128.14 (CH),  122.73 (CH), 
116.69 (C), 106.59 (C), 106.01 (CH), 36.19 (CH3), 21.65 (CH3), 16.73 (CH3); HPLC-MS (ESI): m/z 
= 317.37 [MH+]. Anal calcd for C16H16N2OS3: C, 60.74; H, 5.10; N, 8.85. Found C, 60.61; H, 5.18; 
N, 8.87. 
6-benzyl-1,4-dimethyl-1,6-dihydro-7H-pyrrolo[2,3-c]pyridin-7-one (21a) 
Yields: 86% (in Toluene), 61% (in dichloromethane), 50% (in acetonitrile).Yellow solid.M.p.: 76 
0C. IR = 1670 cm-1.1H NMR (599.71 MHz, CDCl3, T= 25°C) δ  7.33 (m, 2H), 7.28 (m, 3H), 7.00 
(d, 1H, J = 2.8 Hz), 6.67 (q, 1H, J = 1.4 Hz), 6.25 (d, 1H, J = 2.8 Hz), 5.19 (s, 2H), 4.21 (s, 3H), 
2.18 (d, 3H, J = 1.3 Hz);13C NMR (150.81 MHz, CDCl3, T= 25°C) δ 155.54 (C),  137.89 (C), 
132.65 (C), 131.20 (CH), 128.64 (CH), 128.64 (CH), 127.55 (CH), 127.55 (CH), 127.39 (CH), 
125.43 (CH), 122.49 (C), 111.02 (C), 100.38 (CH),  50.42 (CH2), 35.90 (CH3), 15.06 (CH3); HPLC-
MS (ESI): m/z = 253.31 [MH+].  Anal.calcd for C16H16N2O: C, 76.16; H, 6.39; N, 11.10. Found C, 







Yields: 7.3% (in toluene), 12% (in dichloromethane), 25% (in acetonitrile).White solid. M.p.: 106 
0C. IR = 1671 cm-1. 1H NMR (599.71 MHz, CDCl3, T= 25°C) δ  7.26-7.30 (m, 5H), 6.81 (d, 1H, J = 
3.1 Hz), 6.74 (d, 1H, J = 3.0 Hz), 6.69 (br.s., 1H), 5.19 (s, 2H), 3.91 (s, 3H), 2.36 (s, 3H);13C NMR 
(150.81 MHz, CDCl3, T= 25°C) δ 159.37 (C),  137.86 (C), 137.83 (C), 128.73 (CH), 128.59 (CH), 
128.59 (CH), 127.77 (CH), 127.77 (CH), 127.57 (CH), 127.41 (CH), 116.93 (C), 105.34 (C), 
104.94 (CH),  50.44 (CH2), 35.94 (CH3), 16.31 (CH3); HPLC-MS (ESI): m/z = 253.31 [MH+]. Anal. 




Yields: 56% (in toluene),20%(in dichloromethane). White solid. M.p.: 92 0C. IR = 1723, 1671 cm-1. 
1H NMR (599.71 MHz, CDCl3, T= 25°C) δ  6.77 (d, 1H, J = 2.8 Hz), 6.21 (d, 1H, J = 2.8 Hz), 5.28 
(t, 1H, J =1.3 Hz), 5.08 (t, 1H, J = 1.8 Hz), 4.56 (t, 2H, J = 1.6 Hz), 3.95 (s, 3H), 1.57 (s, 9H);13C 
NMR (150.81 MHz, CDCl3, T= 25°C) δ 158.73 (C), 152.72 (C), 133.27 (C), 131.20 (CH), 129.84 
(C), 121.41 (C), 108.09 (CH), 102.00 (CH2), 82.73 (C), 51.77 (CH2), 36.64 (CH3), 28.12 (CH3), 
28.12 (CH3) 28.12 (CH3); HPLC-MS (ESI): m/z = 263.30 [MH+]. Anal. calcd for C14H18N2O3: C, 




Yields: 14% (in toluene), 30% (in dichloromethane). Colourless oil. IR = 1724, 1671 cm-1. 1H NMR 
(599.71 MHz, CDCl3, T= 25°C) δ  6.55 (d, 1H, J = 3.1 Hz), 6.51 (d, 1H, J = 3.0 Hz), 5.21 (m, 2H), 
4.45 (s, 2H), 3.68 (s, 3H), 1.45 (br.s. 9H);13C NMR (150.81 MHz, CDCl3, T= 25°C) δ 161.73 (C), 
152.72 (C), 133.47 (C), 130.20 (CH), 127.04 (CH), 117.38 (C), 109.61 (CH2), 107.62 (CH), 82.33 
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(C), 52.40 (CH2), 35.80 (CH3) 27.87 (CH3), 27.87 (CH3), 27.87 (CH3); HPLC-MS (ESI): m/z = 




Yields: 5% (in dichloromethane), 65% (in acetonitrile).Yellow solid. M.p.: 75 0C. IR = 1675 cm-1. 
1H NMR (599.71 MHz, CDCl3, T= 25°C) δ  11.19 (br.s., 1H), 6.82 (br.s., 1H), 6.81 (d, 1H, J = 3.1 
Hz), 6.78 (d, 1H, J = 3.1 Hz), 3.97 (s, 3H), 2.44 (s, 3H);13C NMR (150.81 MHz, CDCl3, T= 25°C) δ 
161.31 (C),  139.21 (C), 127.69 (CH), 125.34 (CH), 116.60 (C), 105.20 (C), 104.12 (CH), 36.12 
(CH3), 16.30 (CH3); HPLC-MS (ESI): m/z = 263.30 [MH+]. Anal. calcd for C9H10N2O: C, 66.65; H, 
6.21; N, 17.27. Found C, 66.63; H, 6.11; N, 17.34. 
 
1,4-dimethyl-6-(phenylcarbonyl)-1,6-dihydro-7H-pyrrolo[2,3-c]pyridin-7-one. (21d) 
Yields: 51% (in toluene), 60% (in dichloromethane), 50% (in acetonitrile), 3% (in DMF). Yellow 
solid. M.p.: 93 0C. IR = 1674, 1668 cm-1.1H NMR (599.71 MHz, CDCl3, T= 25°C) δ  7.81 (d, 2H, J 
= 7.9 Hz), 7.58 (m, 1H), 7.46 (m, 2H), 7.06 (d, 1H, J = 2.8, Hz), 7.03 (m, 1H), 6.30 (d, 1H, J = 2.8, 
Hz), 4.07 (s, 3H), 2.25 (s, 3H);13C NMR (150.81 MHz, CDCl3, T= 25°C) δ 173.55 (C), 155.56 (C), 
134.28 (C), 133.75 (C), 133.13 (CH), 132.57 (CH), 129.39 (CH), 129.39 (CH), 128.47 (CH), 
128.47 (CH), 121.92 (CH), 121.60 (C), 112.24 (C),  101.48 (CH), 36.15 (CH3), 15.05 (CH3); 
HPLC-MS (ESI): m/z = 267.29 [MH+]. Anal. calcd for C16H14N2O2: C, 72.16; H, 5.30; N, 10.52. 
Found C, 72.19; H, 5.41; N, 10.46. 
 
1,7-dimethyl-5-(phenylcarbonyl)-1,5-dihydro-4H-pyrrolo[3,2-c]pyridin-4-one. (22d) 
Yield: 10% (in dichloromethane), 13% (in acetonitrile). Yellow solid. M.p.: 165 0C. IR = 1673, 
1669 cm-1.1H NMR (599.71 MHz, CDCl3, T= 25°C) δ  7.78 (d, 2H, J = 7.6 Hz), 7.56 (t, 1H, J = 7.6 
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Hz), 7.44 (t, 2H, J = 7.9 Hz), 7.13 (s, 1H), 6.76 (m, 2H), 3.97 (s, 3H), 2.46 (s, 3H);13C NMR 
(150.81 MHz, CDCl3, T= 25°C) δ 173.53 (C), 159.42 (C), 138.30 (C), 134.14 (C), 133.00 (CH), 
129.42 (CH),  129.42 (CH), 128.39 (CH), 128.39 (CH), 128.05 (CH), 125.16 (CH), 116.74 (C), 
107.00 (C), 106.18 (C),  36.20 (CH3), 16.49 (CH3); HPLC-MS (ESI): m/z = 267.29 [MH+]. Anal. 
calcd for C16H14N2O2: C, 72.16; H, 5.30; N, 10.52. Found C, 72.21; H, 5.25; N, 10.49. 
1-methyl-4-methylidene-6-(phenylcarbonyl)-1,4,5,6-tetrahydro-7H-pyrrolo[2,3-c]pyridin-7-
one. (23d) 
Yield: 9% (in toluene).White solid. M.p.: 127 0C. IR = 1670 cm-1. 1H NMR (599.71 MHz, CDCl3, 
T= 25°C) δ  7.60 (dd, 2H, J = 8.1, 1.0 Hz), 7.48 (m, 1H), 7.40 (m, 2H), 6.85 (d, 1H, J = 2.8 Hz), 
6.32 (d, 1H, J = 2.6 Hz), 5.41 (s, 1H), 5.21 (s, 1H), 4.71 (s, 2H), 3.86 (s, 3H);13C NMR (150.81 
MHz, CDCl3, T= 25°C) δ 173.47 (C), 159.94 (C), 136.79 (C), 133.13 (C), 131.96 (CH), 131.27 
(CH),  131.13 (CH), 127.99 (CH), 127.99 (CH), 127.92 (CH), 127.92 (CH), 120.58 (C), 109.03 
(CH2), 102.67 (CH), 51.88 (CH2),  36.56 (CH3); HPLC-MS (ESI): m/z = 267.29 [MH+]. Anal. calcd 
for C16H14N2O2: C, 72.16; H, 5.30; N, 10.52. Found C, 72.21; H, 5.42; N, 10.46. 
1,4-dimethyl-1,6-dihydro-7H-pyrrolo[2,3-c]pyridin-7-one. (25d) 
Yield: 6% (in toluene), 40% (in DMF). Yellow solid. M.p.: 116 0C. IR = 1671 cm-1. 1H NMR 
(599.71 MHz, CDCl3, T= 25°C) δ  11.34 (br.s., 1H), 7.09 (d, 1H, J = 2.8 Hz), 6.77 (s, 1H), 6.34 (d, 
1H, J = 2.8 Hz), 4.20 (s, 3H), 2.26 (d, 3H, J = 0.8 Hz);13C NMR (150.81 MHz, CDCl3, T= 25°C) δ 
156.54 (C), 133.89 (C), 131.18 (CH), 122.24 (C), 121. 0 (CH), 111.11 (C),  100.79 (CH), 35.73 
(CH3), 14.88 (CH3); HPLC-MS (ESI): m/z = 163.18 [MH+]. Anal. calcd for C9H10N2O: C, 66.65; H, 
6.21; N, 17.27. Found C, 66.59; H, 6.16; N, 17.32. 
For 26d see 26c 
1,7-dimethyl-4-phenyl-6,7-dihydropyrrolo[2,3-c]azepin-8(1H)-one. (27e) 
Yields: 20% (in dichloromethane), 43% (in acetonitrile), 66% (in DMF). White solid. M.p.; 118 0C. 
IR = 1673 cm-1. 1H NMR (599.71 MHz, CDCl3, T= 25°C) δ  7.39 (m, 2H), 7.35 (m, 3H), 6.73 (d, 
83 
 
1H, J = 2.8 Hz), 6.07 (t, 1H, J = 6.9 Hz), 5.95 (d, 1H, J = 2.8 Hz), 4.00 (s, 3H), 3.78 (d, 2H, J = 6.9 
Hz), 3.17 (s, 3H);13C NMR (150.81 MHz, CDCl3, T= 25°C) δ 162.21 (C), 142.64 (C), 140.52 (C), 
128.57 (CH), 128.57 (CH), 128.10 (CH),  128.10 (CH), 127.78 (CH), 127.14 (C), 126.78 (CH), 
126.68 (C), 119.60 (CH), 107.73 (CH), 47.53 (CH2), 36.62 (CH3), 34.65 (CH3); HPLC-MS (ESI): 
m/z = 253.31 [MH+]. Anal. calcd for C16H16N2O: C, 76.16; H, 6.39; N, 11.10. Found C, 76.24; H, 
6.35; N, 11.04. 
 
1,5-dimethyl-8-phenyl-5,6-dihydropyrrolo[3,2-c]azepin-4(1H)-one. (28e) 
Yields: 63% (in dichloromethane), 31% (in acetonitrile), 12% (in DMF). White solid. M.p.: 130 0C. 
IR: = 1676 cm-1. 1H NMR (599.71 MHz, CDCl3, T= 25°C) δ  7.34 (m, 3H), 7.22 (d, 2H, J = 6.4 
Hz), 6.77 (d, 1H, J = 2.8 Hz), 6.63 (d, 1H, J = 2.8 Hz), 6.13 (t, 1H, J = 7.4 Hz), 3.74 (d, 2H, J = 7.1 
Hz), 3.17 (s, 3H), 3.07 (s, 3H);13C NMR (150.81 MHz, CDCl3, T= 25°C) δ 166.02 (C), 139.38 (C), 
137.87 (C), 131.50 (C), 128.67 (CH), 128.67 (CH), 128.04 (CH), 127.51 (CH), 127.51 (CH), 
124.74 (CH), 124.31 (CH), 123.28 (C), 109.68 (CH), 47.55 (CH2), 36.44 (CH3), 35.38 (CH3); 
HPLC-MS (ESI): m/z = 253.32 [MH+]. Anal. calcd for C16H16N2O: C, 76.16; H, 6.39; N, 11.10. 




Yields: 20% (in dichloromethane), 55% (in acetonitrile), 68% (in DMF). White solid. M.p.: 190 0C. 
IR: = 1673 cm-1.1H NMR (599.71 MHz, CDCl3, T= 25°C) δ  7.85 (d, 2H, J = 8.2 Hz), 7.37 (m, 5H), 
7.25 (d, 2H), 6.78 (d, 1H, J = 2.6 Hz), 6.34 (t, 1H, J= 7.0 Hz), 5.93 (d, 1H, J = 2.8 Hz), 4.54 (br.s., 
2H), 3.91 (s, 3H), 2.39 (s, 3H);13C NMR (150.81 MHz, CDCl3, T= 25°C) δ 160.72 (C), 144.33 (C), 
143.35 (C), 140.08 (C), 136.22 (C), 129.56 (CH), 129.38 (CH), 129.38 (CH), 128.98 (C), 128.57 
(CH), 128.57 (CH), 128.56 (CH), 128.56 (CH), 128.26 (CH), 128.26 (CH), 128.14 (CH), 124.60 
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(C), 121.46 (CH), 109.05 (CH), 43.35 (CH2), 37.13 (CH3), 21.63 (CH3); HPLC-MS (ESI): m/z = 




Yield: 60% (in dichloromethane), 17% (in acetonitrile), 7% (in DMF). White solid. M.p.: 154 0C. 
IR = 1674 cm-1. 1H NMR (599.71 MHz, CDCl3, T= 25°C) δ  7.90 (d, 2H, J = 8.2 Hz), 7.39 (m, 3H), 
7.26 (d, 2H, J = 8.2 Hz), 7.22 (m, 2H), 6.71 (d, 1H, J= 3.0 Hz), 6.62 (d, 1H, J = 3.0 Hz), 6.42 (t, 
1H, J = 7.6 Hz), 4.87 (br.s.,1H), 3.88 (br.s., 1H), 3.06 (s, 3H), 2.40 (s, 3H);13C NMR (150.81 MHz, 
CDCl3, T= 25°C) δ 164.12 (C), 144.20 (C), 138.99 (C), 138.66 (C), 136.51 (C), 132.37 (C), 129.27 
(CH), 129.27 (CH), 128.91 (CH), 128.91 (CH), 128.57 (CH), 128.57 (CH), 128.48 (CH), 127.49 
(CH), 127.49 (CH), 126.19 (CH), 125.51 (CH), 121.48 (C), 110.88 (CH), 43.31 (CH2), 36.83 (CH3), 
21.60 (CH3); HPLC-MS (ESI): m/z = 393.47 [MH+]. Anal. calcd for C22H20N2O3S: C, 67.33; H, 
5.14; N, 7.14. Found C, 67.25; H, 5.26; N, 7.06. 
7-benzyl-1-methyl-4-phenyl-6,7-dihydropyrrolo[2,3-c]azepin-8(1H)-one (27g) 
Yields: 12% (in dichloromethane), 23% (in acetonitrile), 66% (in DMF). Light yellow solid. M.p.: 
106 0C. IR = 1675 cm-1.1H NMR (599.71 MHz, CDCl3, T= 25°C) δ  7.35 (m, 9H), 7.26 (m, 1H), 
6.76 (d, 1H, J = 2.8 Hz), 5.96 (d, 1H, J = 2.6 Hz), 5.89 (t, 1H, J = 6.9 Hz), 4.79 (s, 2H), 4.05 (s 
,3H), 3.75 (d, 2H, J = 6.92 Hz);13C NMR (150.81 MHz, CDCl3, T= 25°C) δ 162.32 (C), 142.42 (C), 
140.59 (C), 138.08 (C), 128.59 (CH), 128.59 (CH), 128.56 (CH), 128.56 (CH), 128.08 (CH), 
128.08 (CH), 127.89 (CH), 127.89 (CH), 127.72 (CH), 127.29 (CH), 127.05 (CH), 126.88 (C), 
126.81 (C), 120.25 (CH), 107.87 (CH), 50.36 (CH2), 45.21 (CH2), 36.80 (CH3); HPLC-MS (ESI): 
m/z = 329.40 [MH+]. Anal. calcd for C22H20N2O: C, 80.46; H, 6.14; N, 8.53. Found C, 80.41; H, 





Yield: 74% (in dichloromethane), 67% (in acetonitrile), 14% (in DMF). Light yellow solid. M.p.: 
80 0C. IR = 1676 cm-1.1H NMR (599.71 MHz, CDCl3, T= 25°C) δ  7.29 (m, 10H), 6.85 (d, 1H, J = 
3.0 Hz), 6.67 (d, 1H, J = 3.0 Hz), 5.95 (t, 1H, J = 7.4 Hz), 4.81 (br.s., 2H), 3.70 (d, 2H, J = 7.2 Hz), 
3.08 (s ,3H);13C NMR (150.81 MHz, CDCl3, T= 25°C) δ 166.03 (C), 139.57 (C), 138.36 (C), 
137.83 (C), 131.51 (C), 128.70 (CH), 128.70 (CH), 128.48 (CH), 128.02 (CH), 127.95 (CH), 
127.95 (CH), 127.95 (CH), 127.58 (CH), 127.58 (CH), 127.17 (CH), 125.10 (CH), 124.79 (CH), 
110.02 (CH), 50.60 (CH2), 44.94 (CH2), 36.50 (CH3); HPLC-MS (ESI): m/z = 329.40 [MH+]. Anal. 
calcd for C22H20N2O: C, 80.46; H, 6.14; N, 8.53. Found C, 80.34; H, 6.25; N, 8.48. 
 
2-aminophenol (29) 
The compound is commercial available by Sigma Aldrich. 
Propargylbromide (30) 
The compound is commercial available by Sigma Aldrich. 
1-bromo-2-butyne (30a) 
The compound is commercial available by Sigma Aldrich. 
(3-bromoprop-1-yn-1-yl)benzene (30b) 
The compound is known in literature87. 
Preparation of 2-(prop-2-yn-1-ylamino)phenol (31a) 
To a solution of 2-aminophenol (29) (45.8 mmol) in EtOH (130 ml) was slowly dropped 
propargylbromide (30) (9.16 mmol) at room temperature.The mixture was left under stirring at rt 
for 4 days. Solvent was evaporated under reduced prssu e. The residue was washed with TBME 
(100 ml) and the solid preicipitate was filtered-off. The solution was then evaporated under reduced 




Yield: 75%. Pale yellow solid. M. p.: 96-97 °C. IR = 2132, 3305, 3388, 3495 cm-1.
 1H NMR (599 
MHz, CDCl3, T= 25°C) δ: 2.25 (1H, t, J = 2.39 Hz), 3.96 (2H, d, J = 2.31 Hz), 4.56 (2H, br.s.), 6.74 
(1H, m), 6.76 (1H, m), 6.84 (1H, m), 6.91 (1H, m);13C NMR (150.81 MHz, CDCl3, T = 25°C) δ: 
34.4 (CH2), 71.6 (C), 81.3 (C), 114.2 (CH), 114.8 (CH), 119.7 (CH), 121.7 (CH), 135.6 (C), 144.6 
(C); HPLC-MS (ESI): m/z = 148.17 [MH+]. Anal. Calcd for C9H9NO: C, 73.45; H, 6.16; N, 9.52; 
found: C, 73.61; H, 5.90; N, 9.44. 
Synthesis of N-(2-hydroxyphenyl)benzamide (36) 
To a stirred solution of 2-aminophenol (29) (81.5 mmol) and pyridine (32.4 ml) in dry 
dichloromethane (816 ml) was slowly dropped a soluti n of benzoylchloride (85.5 mmol) in dry 
dichloromethane (80 ml)  at 0°C. The mixture was allowed to rt and left at this temperature for 
further 3 hours. The organic phase was then washed thr e times with an aqueous solution of HCl 2N 
(3x 80 ml), then two times with an aqueous solution of NaHCO3 sat.(2x100 ml) and other two times 
with water (2x 100 ml). The aqueous phase was discharged and the organic one was dried over 
Na2SO4, filtered on a gouch and the solvent evaporated under reduced pressure. The crude residue 
was triturated in TBME (80 ml), filtered and the solid dried in the oven at 40 0C. 
 
Yield: 97%. White solid. 1H NMR (599 MHz, CDCl3, T= 25°C) δ: 6.94 (1H, m), 7.09 (1H, d, J = 
8.2 Hz), 7.18 (1H, m), 7.21 (1H, d, J = 7.9 Hz), 7.53 (2H, t, J = 7.9 Hz), 7.62 (1H, m), 7.92 (2H, d, 
J = 7.6 Hz), 8.12 (1H, br.s.), 8.62 (1H, br.s.);13C NMR (150.81 MHz, CDCl3, T = 25°C) δ: 119.9 
(CH), 120.6 (CH), 122.3 (CH), 125.6 (C), 127.3 (CH), 127.3 (CH), 127.3 (CH), 128.9 (CH), 128.9 
(CH), 132.5 (CH), 133.1 (C), 148.8 (C), 167.1 (C); HPLC-MS (ESI): m/z = 214.23 [MH+].  
 
Synthesis of 2-(benzylamino)phenol (37) 
To a solution of BH3THF 1M (19 ml) diluted with THF dry (10 ml), was slowly dropped a solution 
of N-(2-hydroxyphenyl)benzamide (36) (4.7 mmol) in THF dry (10 ml) keeping the internal 
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temperature at rt. The solution was left under stirring for 1.5h then cooled down to 0°C and 
quenched dropping  MeOH (20 ml) in 20 minutes. Temprature was raised to rt and the solution 
was stirred for further 0.5h. Methanol was evaporated under reduced pressure to dryness. 
Yield: 95%. Gray solid.1H NMR (599 MHz, CDCl3, T= 25°C) δ: 4.37 (2H, s), 4.70 (1H, br.s.), 6.64 
(1H, t, J = 7.6 Hz), 6.69 (1H, d, J = 7.6 Hz), 6.73 (1H, d, J = 7.6 Hz), 6.84 (1H, t, J = 7.58 Hz), 
7.29 (1H, t, J = 7.2 Hz), 7.36 (2H, t, J = 7.6 Hz), 7.41 (2H, d, J = 7.6 Hz );13C NMR (150.81 MHz, 
CDCl3, T = 25°C) δ: 48.5 (CH2), 112.3 (CH), 114.2 (CH), 117.6 (CH), 121.6 (CH), 127.1 (CH), 
127.5 (CH), 127.5 (CH), 128.5 (CH), 128.5 (CH), 136.9 (C), 139.4 (C), 143.4 (C); HPLC-MS 
(ESI): m/z = 200.24 [MH+].  
 
Synthesis of  N-(2-hydroxyphenyl)-N-(prop-2-yn-1-yl)benzamide (31b) 
To a stirred solution of 2-(prop-2-yn-1-ylamino)phenol (31a) (6.7 mmol) and pyridine (2.7 ml) in 
dry dichloromethane (68 ml) was slowly dropped a soluti n of benzoylchloride (7.1 mmol) in dry 
dichloromethane (6,7 ml) at 0 C. The mixture was allowed to rt and left at this temperature for 
further 3 hours. The organic phase was then washed thr e times with an aqueous solution of  HCl 
2N (3x 16 ml), then two times with an aqueous soluti n of NaHCO3 sat.(2x20 ml) and other two 
times with water (2x 30 ml). The aqueous phase was discharged and the organic one was dried over 
Na2SO4, filtered on a gouch and the solvent evaporated under reduced pressure. The crude residue 
was triturated in TBME (20 ml), filtered and the solid dried in the oven at 40°C. 
Yield: 70%. White solid. M.p.: 156-158 °C. IR (nujol): 2133, 1698, 3290, 3325 cm-1. 1H NMR (599 
MHz, CDCl3, T= 25°C) δ: 2.32 (1H, d, br.s.), 4.58 (2H, d, br.s.), 6.09 (1H, br.s.), 6.77 (1H, br.s.), 
6.94 (2H, m), 7.27 (6H, m);13C NMR (150.81 MHz, CDCl3, T = 25°C) δ: 38.6 (CH2), 72.8 (CH), 
79.0 (C), 116.9 (CH), 121.1 (CH), 127.8 (CH), 127.9 (CH), 127.9 (CH), 129.6 (CH), 129.7 (CH), 
129.7 (CH), 130.0 (C), 130.3 (CH), 134.5 (C), 151.8 (C), 171.5 (C); HPLC-MS (ESI): m/z = 252.27 
[MH+]. Anal. Calcd for C16H13NO2: C, 76.48; H, 5.21; N, 5.57; found: C, 76.27; H, 5.43; N, 5.75. 
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Synthesis of N-(2-hydroxyphenyl)-N-(prop-2-yn-1-yl)acetamide (31c) 
To a stirred solution of 2-(prop-2-yn-1-ylamino)phenol (31a) (6.7 mmol) and pyridine (2.7 ml) in 
dry dichloromethane (68 ml) was slowly dropped a soluti n of acetylchloride (0.5 ml)  in dry 
dchloromethane (6,7 ml) at 0oC. The mixture was allowed to rt and left at this temperature for 
further 1 hour. The organic phase was then washed thr e times with an aqueous solution of HCl 2N 
(3x 16 ml), then two times with an aqueous solution of NaHCO3 sat.(2x20 ml) and other two times 
with water (2x 30 ml). The aqueous phase was discharged and the organic one was dried over 
Na2SO4, filtered on a gouch and the solvent evaporated under reduced pressure. The crude residue 
was triturated in TBME (20 ml), filtered and the solid dried in the oven at 40°C. 
Yield: 75%. White solid. M.p.: 158-159 °C. IR (nujol): 2120, 1675, 3296 cm-1. 1H NMR (599 MHz, 
CDCl3, T= 25°C) δ: 1.89 (3H, s), 2.27 (1H, t, J = 2.3 Hz), 4.48 (2H, m), 6.69 (1H, br.s.), 6.98 (1H, t, 
J = 7.5 Hz), 7.07 (1H, d, J = 8.2 Hz), 7.21 (1H, m), 7.32 (1H, m);13C NMR (150.81 MHz, CDCl3, T 
= 25°C) δ: 22.0 (CH3), 37.5 (CH2), 72.6 (CH), 79.0 (C), 117.5 (CH), 121.2 (CH), 128.4 (C), 129.0 
(CH), 130.5 (CH), 152.6 (C), 171.8 (C); HPLC-MS (ESI): m/z = 190.21 [MH+]. Anal. Calcd for 
C11H11NO2: C, 69.83; H, 5.86; N, 7.40; found: C, 69.81; H, 6.01; N, 7.23. 
 
Synthesis of N-(2-hydroxyphenyl)-4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide (31d) 
To a stirred solution of 2-(prop-2-yn-1-ylamino)phenol (31a) (6.8 mmol) and pyridine (2.7 ml) in 
dry dichloromethane (68 ml) was slowly dropped a soluti n of tosylchloride (7.1 mmol) in dry 
dchloromethane (6,7 ml) at 0oC. The mixture was allowed to rt and left at this temperature for 
further 1 hour. The organic phase was then washed thr e times with an aqueous solution of HCl 2N 
(3x 16 ml), then two times with an aqueous solution of NaHCO3 sat.(2x20 ml) and other two times 
with water (2x 30 ml). The aqueous phase was discharged and the organic one was dried over 
Na2SO4, filtered on a gouch and the solvent evaporated under reduced pressure. The crude residue 
was purified by flash chromatography column (Cyclohexane / EtOAc 8:2) 
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Yield: 80%. Pale yellow solid. M.p.: 165-166 °C. IR(nujol): 2135, 3266, 3415 cm-1.1H NMR (599 
MHz, CDCl3, T= 25°C) δ: 2.21 (1H, t, J = 2.4 Hz),  2.44 (3H, s), 4.39 (2H, d, J = 1.32 Hz), 6.54 
(1H, s), 6.71 (2H, m), 7.06 (1H, m), 7.23 (1H, m), 7.27 (2H, s), 7.59 (2H, d, J = 8.24 Hz);13C NMR 
(150.81 MHz, CDCl3, T = 25°C) δ: 21.6 (CH3), 41.7 (CH2), 74.1 (CH), 77.5 (C), 117.4 (CH), 120.4 
(CH), 125.7 (C), 128.1 (CH), 128.4 (CH), 128.4 (CH), 129.4 (CH), 129.4 (CH), 130.5 (CH), 133.8 
(C), 144.5 (C), 154.4 (C); HPLC-MS (ESI): m/z = 302.36 [MH+]. Anal. calcd for C16H15NO3S: C, 
63.77; H, 5.02; N, 4.65; found: C, 63.92; H, 4.83; N. 4.69. 
 
Synthesis of 2-[benzyl(prop-2-yn-1-yl)amino]phenol (31e) 
To a solution of 2-(benzylamino)phenol (37) (80 mmol) in EtOH (400 ml) was slowly dropped 
propargylbromide (30) (16 mmol) at room temperature.The mixture was left under stirring at rt for 
4 days. Solvent was evaporated under reduced pressure. The crude residue was purified by flash 
chromatography column. (Cyclohexane / Cyclopentylmethyl ther, 9:1) 
Yield: 70%. Red oil. IR (nujol): 2112, 3312, 3392 cm-1. 1H NMR (599 MHz, CDCl3, T= 25°C) δ: 
2.33 (1H, m, J = 1.3 Hz), 3.58 (2H, d, J = 2.3 Hz), 4.16 (2H, s), 6.88 (1H, t, J = 7.7 Hz), 6.94 (1H, 
d, J = 8.2 Hz), 7.11 (1H, t, J = 7.7 Hz), 7.29 (1H, m), 7.34 (4H, m), 7.41 (1H, d, J = 7.6 Hz);13C 
NMR (150.81 MHz, CDCl3, T = 25°C) δ: 42.7 (CH2), 57.2 (CH2), 73.8 (CH), 78.8 (C), 114.1 (CH), 
119.8 (CH), 124.0 (CH), 127.1 (CH), 127.7 (CH), 128.5 (CH), 128.5 (CH), 129.26 (CH), 129.26 
(CH), 136. 8 (C), 137.0 (C), 151.9 (C); HPLC-MS (ESI): m/z = 238.29 [MH+]. Anal. Calcd for 
C16H15NO: C, 80.98; H, 6.37; N, 5.90; found: C, 81.14; H, 6.20; N, 5.96. 
 
Synthesis of 2-[(3-phenylprop-2-yn-1-yl)amino]phenol (38a) 
To a solution of 2-aminophenol (29) (93.5 mmol) in EtOH (200 ml) was slowly dropped (3-
bromoprop-1-yn-1-yl)benzene (30a) (18.7 mmol) at room temperature.The mixture was left under 
stirring at rt for 4 days. Solvent was evaporated un er reduced pressure. The residue was washed 
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with TBME (100 ml) and the solid preicipitate was filtered-off. The solution was then evaporated 
under reduced pressure. The crude residue was purified by flash chromatography column. 
(Cyclohexane / EtOAc, 8 :2) 
Yield: 63%. Light yellow solid. 1H NMR (599 MHz, CDCl3, T= 25°C) δ: 4.17 (2H, s), 4.25 (2H, q, 
J = 2.31 Hz), 4.56 (2H, br.s.), 6.72 (1H, m), 6.75 (1H, m), 6.82 (1H, dd, J = 7.9, 1.3 Hz), 6.90 (1H, 
m);13C NMR (150.81 MHz, CDCl3, T = 25°C) δ: 3.5 (CH3), 34.6 (CH2), 76.1 (C), 79.2 (C), 113.9 
(CH), 114.5 (CH), 119.1 (CH), 121.5 (CH), 135.8 (C), 144.4 (C); HPLC-MS (ESI): m/z = 151.81 
[MH+].  
Synthesis of 2-(but-2-yn-1-ylamino)phenol (38a) 
To a solution of 2-aminophenol (29) (93.5 mmol) in EtOH (200 ml) was slowly dropped 1-bromo-
2-butyne (30a) (18.7 mmol) at room temperature.The mixture was left under stirring at rt for 4 days. 
Solvent was evaporated under reduced pressure. The residue was washed with TBME (100 ml) and 
the solid preicipitate was filtered-off. The solution was then evaporated under reduced pressure. The 
crude residue was purified by flash chromatography column. (Cyclohexane / EtOAc, 7.5:2.5) 
Yield: 60%. Light brown solid. 1H NMR (599 MHz, CDCl3, T= 25°C) δ: 1.82 (3H, t, J = 2.47 Hz), 
3.88 (2H, q, J = 2.31 Hz), 4.56 (2H, br.s.), 6.72 (1H, m), 6.75 (1H, m), 6.82 (1H, dd, J = 7.9, 1.3 
Hz), 6.90 (1H, m);13C NMR (150.81 MHz, CDCl3, T = 25°C) δ: 3.5 (CH3), 34.6 (CH2), 76.1 (C), 
79.2 (C), 113.9 (CH), 114.5 (CH), 119.1 (CH), 121.5 (CH), 135.8 (C), 144.4 (C); HPLC-MS (ESI): 
m/z = 151.81 [MH+].  
N-(but-2-yn-1-yl)-N-(2-hydroxyphenyl)benzamide (31f) 
To a stirred solution of 2-(but-2-yn-1-ylamino)phenol (38a) (5.4 mmol) and pyridine (2.1 ml) in dry 
dichloromethane (54 ml) was slowly dropped a solutin of benzoylchloride (5.7 mmol)  in dry 
dichloromethane (5.3 ml) at 0°C. The mixture was allowed to rt and left at this temperature for 
further 3 hours. The organic phase was then washed thr e times with an aqueous solution of HCl 2N 
(3x 16 ml), then two times with an aqueous solution of NaHCO3 sat.(2x20 ml) and other two times 
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with water (2x 30 ml). The aqueous phase was discharged and the organic one was dried over 
Na2SO4, filtered on a gouch and the solvent evaporated under reduced pressure. The crude residue 
was triturated in TBME (15 ml),  filtered and the solid dried in the oven at 40°C. 
Yield: 80%. White solid. M.p.: 142-143 °C. IR (nujol): 2208, 1715, 3275 cm-1.1H NMR (599 MHz, 
CDCl3, T= 25°C) δ: 1.81 (3H, t, J = 2.3 Hz), 4.53 (2H, m), 6.72 (1H, br.s.), 6.91 (2H, m) 7.11 (1H, 
m), 7.15 (2H, br.s.) 7.24 (1H, br.s.), 7.37 (2H, br.s.);13C NMR (150.81 MHz, CDCl3, T = 25°C) δ: 
3.58 (CH3), 39.0 (CH2), 74.3 (C), 80.8 (C), 117.0 (CH), 120.7 (CH), 127.7 (CH), 127.7 (CH), 127.8 
(CH), 127.8 (CH), 129.5 (CH), 129.8 (CH), 130.0 (C), 130.0 (CH), 134.8 (C), 152.2 (C), 171.6 (C); 
HPLC-MS (ESI): m/z = 266.30 [MH+]. Anal. Calcd for C17H15NO2: C, 76.96; H, 5.70; N, 5.28; 
found: C, 76.99; H, 5.83; N, 5.21. 
 
Synthesis of 2-[(3-phenylprop-2-yn-1-yl)amino]phenol (38b) 
To a solution of 2-aminophenol (29) (93.5 mmol) in EtOH (200 ml) was slowly dropped (3-
bromoprop-1-yn-1-yl)benzene (30b) (18.7 mmol) at room temperature.The mixture was left under 
stirring at rt for 4 days. Solvent was evaporated un er reduced pressure. The residue was washed 
with TBME (100 ml) and the solid preicipitate was filtered-off. The solution was then evaporated 
under reduced pressure. The crude residue was purified by flash chromatography column. 
(Cyclohexane / EtOAc, 8 :2) 
Yield: 63%. Light yellow solid. 1H NMR (599 MHz, CDCl3, T= 25°C) δ: 4.17 (2H, s), 4.25 (1H, 
br.s.), 5.21 (1H, br.s.), 6.76 (2H, m), 6.93 (2H, m) 7.31 (3H, m), 7.42 (2H, m);13C NMR (150.81 
MHz, CDCl3, T = 25°C) δ: 35.1 (CH2), 83.43 (C), 86.4 (C), 114.2 (CH), 114.5 (CH), 119.5 (CH), 
121.5 (CH), 122.8 (C), 128.1 (CH), 128.2 (CH), 128.2 (CH), 131.7 (CH), 131.7 (CH), 135.6 (C), 




Synthesis of N-(2-hydroxyphenyl)-4-methyl-N-(3-phenylprop-2-yn-1-yl)benzenesulfonamide 
(31g) 
To a stirred solution of 2-[(3-phenylprop-2-yn-1-yl)amino]phenol (38b) (5.4 mmol) and pyridine 
(2.1 ml) in dry dichloromethane (54 ml) was slowly dropped a solution of tosylchloride (5.7 mmol) 
in dry dichloromethane (5.3 ml) at 0°C. The mixture was allowed to rt and left at this temperature 
for further 3 hours. The organic phase was then washed three times with an aqueous solution of HCl 
2N (3x 16 ml), then two times with an aqueous soluti n of NaHCO3 sat.(2x20 ml) and other two 
times with water (2x 30 ml). The aqueous phase was discharged and the organic one was dried over 
Na2SO4, filtered on a gouch and the solvent evaporated under reduced pressure. The crude residue 
was triturated in TBME (15 ml), filtered and the solid dried in the oven at 40°C. 
Yield: 60%. Pale yellow solid. M.p.: 168 °C. IR (nujol): 2215, 3324 cm-1.1H NMR (599 MHz, 
CDCl3, T= 25°C) δ: 2.41 (3H, s), 4.63 (2H, br.s.), 6.63 (1H, s), 6.75 (1H, m), 6.84 (1H, dd, J = 8.0, 
1.5 Hz), 7.09 (1H, dd, J = 8.2, 1.3 Hz) 7.27 (7H, m), 7.65 (2H, d, J = 8.2 Hz);13C NMR (150.81 
MHz, CDCl3, T = 25°C) δ: 21.6 (CH3), 42.7 (CH2), 82.9 (C), 85.9 (C), 117.4 (CH), 120.4 (CH), 
122.0 (C), 126.1 (C), 128.2 (CH), 128.2 (CH), 128.5 (CH), 128.5 (CH), 128.6 (CH), 129.4 (CH), 
129.4 (CH), 130.5 (CH), 130.5 (CH), 131.5 (CH), 131.5 (CH), 134.2 (C), 144.3 (C), 154.5 (C); 
HPLC-MS (ESI): m/z = 378.45 [MH+]. Anal. Calcd for C22H19NO3S: C, 70.00; H, 5.07; N. 3.71; 
found: C, 70.18; H, 4.81; N. 3.52. 
 
Synthesis of 2-(prop-2-yn-1-yloxy)phenol (41) 
The compound is known in letterature88. 
Synthesis of 3-(prop-2-yn-1-yloxy)naphthalen-2-ol (42) 
The compound is known in letterature88. 
White solid. . 1H NMR (599 MHz, CDCl3, T= 25°C) δ: 2.62 (1H, t, J = 2.3 Hz), 4.90 (2H, d, J = 2.3 
Hz), 5.88 (1H, s), 7.26 (1H, s), 7.31 (1H, s), 7.34 (1H, m) 7.37 (1H, m), 7.68 (1H, d, J = 7.9 Hz), 
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7.71 (1H, d, J = 7.58 Hz);13C NMR (150.81 MHz, CDCl3, T = 25°C) δ: 56.7 (CH2), 76.5 (CH), 77.6 
(C), 107.5 (CH), 109.9 (CH), 123.9 (CH), 124.7 (CH), 126.3 (CH), 126.6 (CH), 128.6 (C), 130.0 
(C), 145.2 (C), 145.5 (C); HPLC-MS (ESI): m/z = 199.21 [MH+].  
 
Synthesis of 2-methylidene-3,4-dihydro-2H-1,4-benzoxazine (32a) 
To a solution of 2-(prop-2-yn-1-ylamino)phenol (31a)  (3.98 mmol) in dry acetonitrile (120 ml) , 
K2CO3 (0.39 mmol) and AuCl ( 0.19 mmol) were added. The mixture was refluxed for 8h. At the 
end of this time the solvent was evaporated under reduced pressure. The crude residue was purified 
by flash chromatography (Cyclohexane / Cyclopentylmethylether 7:3). 
Yield: 70%. Red oil. IR (nujol): 3352 cm-1. 1H NMR (599 MHz, CDCl3, T= 25°C) δ: 3.68 (2H, d, J 
= 1.9 Hz), 4.25 (1H, d, J = 0.6 Hz), 4.48 (1H,d, J = 0.6 Hz), 5.91 (1H, br.s.), 6.61 (1H, td, J = 7.7, 
1.6 Hz), 6.69 (1H, dd, J= 7.9, 1.65 Hz), 6.76 (1H, td, J = 7.9, 1.3 Hz), 6.80 (1H, d, J = 7.9 Hz);13C 
NMR (150.81 MHz, CDCl3, T = 25°C) δ: 41.9 (CH2), 88.3 (CH2), 115.1 (CH), 115.2 (CH), 118.1 
(CH), 121.8 (CH), 135.2 (C), 142.0 (C), 152.5 (C); HPLC-MS (ESI): m/z = 148.17 [MH+]. Anal. 
calcd for C9H9NO: C, 73.45; H, 6.16; N, 9.52; found: C, 73.62; H, 6.02; N, 9.43 
 
Synthesis of quinolin-8-ol (35a) 
To solution of (31a) (3 mmol) in dry acetonitrile (80 ml), NaAuCl4 was added (0.15 mmol). The 
mixture was refluxed for 24 hours, At the end of this time, the solvent was evaporated under 
reduced pressure and the residue was purified by chromatographic column (Toluene / EtOAc 
6.5:3.5) 






Synthesis of (2-methylidene-2,3-dihydro-4H-1,4-benzoxazin-4-yl)(phenyl)methanone (32b) 
To a solution of N-(2-hydroxyphenyl)-N-(prop-2-yn-1-yl)benzamide (31b) (3.98 mmol) in dry 
acetonitrile (120 ml) , K2CO3 (0.39 mmol) and AuCl ( 0.19 mmol) were added. The mixture was 
refluxed for 8h. At the end of this time the solvent was evaporated under reduced pressure. The 
crude residue was purified by flash chromatography (Cyclohexane / EtOAc 9:1). 
Yield: 60%. Light yellow solid. M.p.: 115-116 °C. IR (nujol): 1694 cm-1.1H NMR (599 MHz, 
CDCl3, T= 25°C) δ: 4.33 (1H, d, br.s.), 4.46 (2H, s), 4.73 (1H, d, J = 1.3 Hz), 6.71 (2H, br.s.), 7.05 
(2H, m), 7.35 (2H, t, J = 6.9 Hz), 7.44 (1H, t, J = 6.9 Hz), 7.48 (2H, d, J = 7.9 Hz);13C NMR 
(150.81 MHz, CDCl3, T = 25°C) δ: 43.9 (CH2), 90.7 (CH2), 116.8 (CH), 121.2 (CH), 124.2 (CH), 
125.9 (CH), 127.2 (C), 128.3 (CH), 128.3 (CH), 128.6 (CH), 130.8 (CH), 130.8 (CH), 134.5 (C), 
145.3 (C), 151.6 (C), 168.4 (C); HPLC-MS (ESI): m/z = 252.27 [MH+]. Anal calcd for C16H13NO2: 
C, 76.48; H, 5.21; N, 5.57; found: C, 76.36; H, 5.32; N, 5.84. 
 
 
Synthesis of 1-(2-methylidene-2,3-dihydro-4H-1,4-benzoxazin-4-yl)ethanone (32c) 
To a solution of N-(2-hydroxyphenyl)-N-(prop-2-yn-1-yl)acetamide (31c) (5.3 mmol) in dry 
acetonitrile (100 ml) , K2CO3 (0.53 mmol) and AuCl ( 0.26 mmol) were added. The mixture was 
refluxed for 5h. At the end of this time the solvent was evaporated under reduced pressure. The 
crude residue was purified by flash chromatography (Cyclohexane / EtOAc 7:3). 
Yield: 60%. Red oil. IR (nujol): 1680 cm-1. 1H NMR (599 MHz, CDCl3, T= 25°C) δ: 2.29 (3H, s), 
4.33 (1H, br.s), 4.38 (1H, d, br.s.), 4.66 (1H, d, J = 1.6 Hz), 7.01 (1H, dt, J = 7.6, 1.3 Hz), 7.05 (1H, 
d, J = 7.9 Hz), 7.16 (2H, m);13C NMR (150.81 MHz, CDCl3, T = 25°C) δ: 22.2 (CH3), 41.8 (CH2), 
90.5 (CH2), 117.0 (CH), 121.6 (CH), 123.8 (CH), 126.7 (CH), 127.4 (C), 146.2 (C), 151.7 (C), 
168.8 (C); HPLC-MS (ESI): m/z = 190.21 [MH+]. Anal. calcd for C11H11NO2: C, 69.83; H, 5.86; N, 
7.40; found: C, 69.67; H, 6.07; N, 7.26. 
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Synthesis of 2-methylidene-4-[(4-methylphenyl)sulfonyl]-3,4-dihydro-2H-1,4-benzoxazine 
(32d) 
To a solution of N-(2-hydroxyphenyl)-4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide (31d) (3.3 
mmol) in dry acetonitrile (100 ml) , K2CO3 (0.33 mmol) and AuCl ( 0.16 mmol) were added. The 
mixture was refluxed for 1h. At the end of this time the solvent was evaporated under reduced 
pressure. The crude residue was purified by flash chromatography (Cyclohexane / EtOAc 9:1). 
Yield: 90%. White solid. M.p.: 172-173 °C. 1H NMR (599 MHz, CDCl3, T= 25°C) δ: 2.36 (3H, s), 
4.06 (1H, s), 4.28 (2H, s), 4.32 (1H, s), 6.85 (1H, d, J = 8.2 Hz), 7.04 (1H, t, J = 7.7 Hz), 7.12 (2H, 
d, J = 7.9 Hz), 7.18 (1H, t, J = 7.7 Hz), 7.35 (2H, d, J = 7.91 Hz), 7.74 (1H, d, J = 8.2 Hz);13C NMR 
(150.81 MHz, CDCl3, T = 25°C) δ: 21.5 (CH3), 46.0 (CH2), 91.3 (CH2), 116.6 (CH), 122.0 (CH), 
124.2 (C), 126.8 (CH), 127.6 (CH), 127.6 (CH), 127.6 (CH), 129.2 (CH), 129.2 (CH), 134.4 (C), 
144.1 (C), 147.1 (C), 148.5 (C); HPLC-MS (ESI): m/z = 302.36 [MH+]. Anal. calcd for 
C16H15NO3S: C, 63.77; H, 5.02; N, 4.65; found: C, 63.85; H, 4.88; N. 4.46. 
 
Synthesis of 4-benzyl-2-methylidene-3,4-dihydro-2H-1,4-benzoxazine (32e) 
To a solution of 2-[benzyl(prop-2-yn-1-yl)amino]phenol (31e) (4.97 mmol) in dry acetonitrile (140 
ml) , K2CO3 (0.49 mmol) and AuCl ( 0.24 mmol) were added. The mixture was refluxed for 5h. At 
the end of this time the solvent was evaporated under reduced pressure. The crude residue was 
purified by flash chromatography (Cyclohexane / Cyclopentylmethylether 9.3:0.7). 
Yield: 65%. Red oil. 1H NMR (599 MHz, CDCl3, T= 25°C) δ: 3.60 (2H, s), 4.13 (1H, d, J = 0.66 
Hz), 4.37 (2H, s), 4.62 (1H, d, J = 1.32 Hz), 6.80 (1H, m), 6.81 (1H, m), 6.89 (1H, m) 6.96 (1H, dd, 
J = 7.7, 1.32 Hz), 7.31 (1H, m), 7.37 (4H, m);13C NMR (150.81 MHz, CDCl3, T = 25°C) δ: 48.4 
(CH2), 54.7 (CH2), 88.8 (CH2), 113.8 (CH), 115.8 (CH), 119.6 (CH), 122.0 (CH), 127.3 (CH), 127.6 
(CH), 127.6 (CH), 128.6 (CH), 128.6 (CH), 135.7 (C), 137.2 (C), 143.7 (C), 152.0 (C); HPLC-MS 
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(ESI): m/z = 238.29 [MH+]. Anal. calcd for C16H15NO: C, 80.98; H, 6.37; N, 5.90; found: C, 81.15; 
H, 6.16; N. 5.73. 
 
Synthesis of [(2Z)-2-ethylidene-2,3-dihydro-4H-1,4-benzoxazin-4-yl](phenyl)methanone (32f-
cis) and [(2E)-2-ethylidene-2,3-dihydro-4H-1,4-benzoxazin-4-yl](phenyl)methanone (32f-trans) 
To a solution of N-(but-2-yn-1-yl)-N-(2-hydroxyphenyl)benzamide (31f) (2.5 mmol) in dry DMF 
(90 ml) , K2CO3 (0.25 mmol) and AuCl3 ( 0.12 mmol) were added. The mixture was refluxed for 
2h. At the end of this time the the mixture was diluted with TBME (200ml), washed with water 
(3x100ml). The organic phase was dried over Na2SO4 and the solvent evaporated under reduced 
pressure. The crude residue was purified by flash chromatography (Cyclohexane / EtOAc, 9:1). 
Yield: 50% (32f-cis). White solid. M.p.: 129-131 °C. IR (nujol): 1705 cm-1. 1H NMR (599 MHz, 
CDCl3, T= 25°C) δ: 1.78 (3H, d, J = 6.9 Hz), 4.38 (2H, br.s.), 4.69 (1H, m), 6.70 (1H, br.s.), 6.70 
(1H, br.s.), 7.05 (1H, m), 7.08 (1H, m), 7.35 (2H, m), 7.43 (1H, m), 7.48 (2H, d, J = 6.9 Hz);13C 
NMR (150.81 MHz, CDCl3, T = 25°C) δ: 9.3 (CH3), 44.7 (CH2), 101.7 (CH), 116.9 (CH), 120.8 
(CH), 124.3 (CH), 125.8 (CH), 127.2 (C), 128.2 (CH), 128.2 (CH), 128.6 (CH), 128.6 (CH), 130.7 
(CH), 134.7 (C), 144.5 (C), 145.5 (C), 168.3(C). HPLC-MS (ESI): m/z = 266.30 [MH+]. Anal. 
Calcd for C17H15NO2: C, 76.96; H, 5.70; N, 5.28; found: C, 77.14; H, 5.51; N, 5.39. 
 
Yield: 30% (32f-trans). White solid. M.p.: 144-145 °C. 1H NMR (599 MHz, CDCl3, T= 25°C) δ: 
2.02 (3H, d, br.s.), 4.51 (2H, m), 4.78 (1H, br.s.), 6.68 (1H, br.s.), 6.80 (1H, br.s.), 7.10 (2H, m), 
7.17 (2H, m), 7.24 (1H, m), 7.33 (2H, d, J = 7.2 Hz);13C NMR (150.81 MHz, CDCl3, T = 25°C) δ: 
22.2 (CH3), 44.4 (CH2), 100.4 (CH), 121.2 (CH), 124.4 (CH), 127.7 (CH), 127.7 (CH), 128.1 (CH), 
128.1 (CH), 128.2 (CH), 129.1 (CH), 129.8 (CH), 135.4 (C), 135.5 (C), 151.0 (C), 152.9 (C), 169.7 
(C); HPLC-MS (ESI): m/z = 266.30 [MH+]. Anal. Calcd for C22H19NO3S: C, 70.01; H, 5.07; N. 
3.71; found: C, 70.11; H, 5.11; N. 3.63. 
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Synthesis of (2Z)-2-benzylidene-4-[(4-methylphenyl)sulfonyl]-3,4-dihydro-2H-1,4-benzoxazine (32g) 
To a solution of N-(2-hydroxyphenyl)-4-methyl-N-(3-phenylprop-2-yn-1-yl)benzenesulfonamide 
(31g) (2.5 mmol) in dry DMF (90 ml) ,K2CO3 (0.25 mmol) and AuCl3 (0.12 mmol) were added. 
The mixture was refluxed for 24h. At the end of this time the the mixture was diluted with TBME 
(200ml), washed with water (3x100ml). The organic phase was dried over Na2SO4 and the solvent 
evaporated under reduced pressure. The crude residue was purified by flash chromatography 
(Cyclohexane / EtOAc,  9:1). 
Yield: 35% (32g-cis). White solid. M.p.: 144-145 °C. 1H NMR (599 MHz, CDCl3, T= 25°C) δ: 2.02 
(3H, s), 4.33 (2H, s), 5.18 (1H, s), 6.89 (2H, d, J = 7.91 Hz), 7.02 (1H, d, J = 7.9 Hz), 7.11 (1H, t, J
= 7.7 Hz), 7.17 (1H, m), 7.26 (5H, m), 7.29 (2H, s), 7.76 (1H, dd, J = 7.9, 0.9 Hz);13C NMR 
(150.81 MHz, CDCl3, T = 25°C) δ: 21.1 (CH3), 47.7 (CH2), 107.8 (CH), 116.8 (CH), 122.4 (CH), 
124.9 (C), 126.5 (CH), 127.4 (CH), 127.4 (CH), 127.5 (CH), 127.9 (CH), 128.0 (CH), 128.0 (CH), 
128.5 (CH), 128.5 (CH), 129.2 (CH), 129.2 (CH), 133.9 (C), 133.9 (C), 141.0 (C), 144.3 (C), 147.2 
(C); HPLC-MS (ESI): m/z = 378.45 [MH+]. Anal. Calcd for C22H19NO3S: C, 70.01; H, 5.07; N. 
3.71; found: C, 70.11; H, 5.11; N. 3.63. 
 
(2Z)-2-benzylidene-2H-1,4-benzoxazine (35c) 
Yield: 5%. Yellow solid. M.p.: 112-113 °C. 1H NMR (599 MHz, CDCl3, T= 25°C) δ: 5.79 (1H, s), 
7.05 (1H, dd, J = 8.0, 1.1 Hz), 7.07 (1H, m), 7.22 (1H, td, J = 7.7, 1.3 Hz), 7.30 (1H, m), 7.38 (1H, 
dd, J = 7.6, 1.3 Hz), 7.41 (2H, t, J = 7.7 Hz), 7.77 (2H, d, J = 7.6 Hz), 7.81 (1H, s);13C NMR 
(150.81 MHz, CDCl3, T = 25°C) δ: 112.5 (CH), 115.3 (CH), 123.9 (CH), 127.8 (CH), 128.1 (CH), 
128.5 (CH), 128.5 (CH), 129.0 (CH), 129.0 (CH), 129.5 (CH), 132.5 (C), 134.0 (C), 143.4 (C), 
145.5 (C), 154.5 (C); HPLC-MS (ESI): m/z = 222.25 [MH+]. HRMS (EI): m/z calcd for C15H11NO: 




Synthesis of 2-methylidene-2,3-dihydro-1,4-benzodioxine (43) 
To a solution of 2-(prop-2-yn-1-yloxy)phenol (41) (6.1 mmol) in dry acetonitrile (100 ml) , K2CO3 
(0.61 mmol) and AuCl ( 0.30 mmol) were added. The mixture was refluxed for 7h. At the end of 
this time the solvent was evaporated under reduced pr ssure. The crude residue was purified by 
flash chromatography (Cyclohexane / EtOAc, 9.7:0.3). 
Yield: 70%. Colourless oil. 1H NMR (599 MHz, CDCl3, T= 25°C) δ: 4.36 (1H, d, J = 1.9 Hz), 4.51 
(2H, s), 4.75 (1H, d,  J = 1.9 Hz), 6.90 (3H, m), 6.97 (1H, m);13C NMR (150.81 MHz, CDCl3, T = 
25°C) δ: 64.6 (CH2), 91.2 (CH2), 116.4 (CH), 117.2 (CH), 122.1 (CH), 122.2 (CH), 142.6 (C), 
143.7 (C), 150.0 (C). 
Synthesis of 2-methylidene-2,3-dihydronaphtho[2,3-b][1,4]dioxine (44) 
To a solution of 3-(prop-2-yn-1-yloxy)naphthalen-2-ol (42) (5.0 mmol) in dry DMF (80 ml) , 
K2CO3 (0.50 mmol) and AuCl ( 0.25 mmol) were added. The mixture was refluxed for 2h. At the 
end of this time the mixture was diluted with TBME (200 ml) and washed four times with water 
(4x80 ml). The aqueous phase was discharged and the organic one was dried over Na2SO4, filtered 
on a gouch and the solvent evaporated under reduced pressure.The crude residue was purified by 
flash chromatography (Cyclohexane / EtOAc, 9.7:0.3). 
Yield: 75%. Light yellow solid. 1H NMR (599 MHz, CDCl3, T= 25°C) δ: 4.43 (1H, d, J = 0.6 Hz), 
4.60 (2H, s), 4.83 (1H, d, J = 0.9 Hz), 7.33 (1H, s), 7.35 (2H, m), 7.37 (1H, s), 7.70 (2H, m);13C 
NMR (150.81 MHz, CDCl3, T = 25°C) δ: 64.8 (CH2), 91.4 (CH2), 112.0 (CH), 112.8 (CH), 124.6 
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